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Long chain polyunsaturated fatty acids (LCPUFA), especially arachidonic acid 
(ARA, 20:4n-6), eicosapentaenoic acid (EPA, 20:5n-3), and docosahexaenoic 
acid (DHA, 22:6n-3) are essential for human health and cognitive 
development, are the major structural components of the cell membranes, are 
precursors for cellular signaling molecules and are also known to regulate 
transcription of genes. It is widely believed that the biosynthesis of LCPUFA 
from linoleic acid (18:2n-6) and linolenic acid (18:3n-3) takes place by 
alternating series of position-specific desaturases, chain-elongation reactions 
and a peroxisomal beta-oxidation for DHA synthesis. The existence of an 
alternative biosynthetic pathway was first observed in a protozoan (Euglena 
gracilis), in which 18:2n-6 and 18:3n-3 are first elongated to 20:2n-6 and 
20:3n-3, followed by ∆8- and ∆5-desaturation, respectively to yield 20:4n-6 
and 20:5n-3. We hypothesized that the primate FADS2 gene product would 
have ∆8-desaturase activity and cloned baboon FADS2 into Saccharomyces 
cerevisiae, to test for gain of ∆8-desaturation activity. The novel data that we 
have published (park et al, 2009, JLR) show evidence that the FADS2 protein 
product is a ∆8-desaturase (as well as a ∆6-desaturase). 
  
FADS1, FADS2, and FADS3 are localized within a 100 kb region on human 
chromosome 11q12-13.1. FADS1 and FADS2 genes encode for enzymes 
catalyzing ∆5- and ∆6- & ∆8-desaturation, respectively and only a single 
transcript has been identified for both genes. Function(s) of FADS3 showing 
high homology to FADS1 and FADS2 are unknown. We reported the results 
for the existence of alternative transcripts (AT) for FADS2 and FADS3 genes. 
Investigating the role of FADS genes, we performed RT-PCR analysis using 
baboon cDNA and detected an AT for FADS2 and multiple AT for FADS3 
generated by alternative splicing (Park et al, 2009, Mol Biol Reports; Park et 
al, 2009, Gene). We also found that these AT are well conserved across 
several vertebrate species. The FADS2 AT and FADS3 AT are expressed in 
many neonate baboon tissues. FADS3 AT also showed changes in 
abundance in response to human neuronal cell differentiation. Determining the 
functions of these AT, conserved among species, provides a putative 
mechanism for understanding of LCPUFA biosynthetic regulation, and how it 
differs among individuals. 
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CHAPTER 1 
 
INTRODUCTION 
 
6.1. Food and LCPUFA 
 
With the growing concerns over optimal nutrition for human health, interests in 
functional food and dietary nutrients have significantly increased. As an 
essential requirement for the human diet, dietary fat is important as it is a 
source of energy as well as as a source of essential fatty acids and fat-soluble 
vitamins. However, regardless of the sufficient supply of fat, the nutritional 
composition of western diet is widely believed to have adversely affected 
human health and contributed to the prevalence of chronic diseases (Roche, 
1999). Nutritional imbalance between n-6 and n-3 fatty acids has been a 
serious concern in the western diet and in developing countries.  High intakes 
of n-6 fatty acids are thought to induce deleterious shifts in blood clotting 
propensity, vasospasm, and vasoconstriction, and decrease in bleeding time 
(Roche, 1999; Simopoulos, 1999).   
 
Mammalian fatty acids consist of hydrocarbon chains with diverse lengths and 
with single or double bonds. The n-6 and n-3 fatty acids are classified 
according to the place of the first double bond close to the methyl end of the 
fatty acid.  Long chain polyunsaturated fatty acid (LCPUFA), of the n-6 and n-3 
families, especially arachidonic acid (ARA, 20:4n-6), eicosapentaenoic acid 
(EPA, 20:5n-3), and docosahexaenoic acid (DHA, 22:6n-6) are the most 
physiologically potent and contribute significantly to human health, especially 
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to vision and cognition during various stages of development and aging. 
However, mammals cannot synthesize these fatty acids from acetyl CoA 
because they lack ∆12- and ∆15- desaturase enzymes, hence, these LCPUFA 
must be directly consumed from diet such as fish, or meat.  They also can be 
synthesized from dietary essential fatty acids (EFA) (Burr and Burr, 1973) 
linoleic acid (LA, 18:2n-6) and α-linolenic acid (ALA, 18:3n-3) by a series of 
desaturation and elongation reactions. The main sources for LA are corn, 
sunflower seeds, safflower seeds, cotton seeds, and soybeans and those for 
ALA are green leafy vegetables, flaxseed, canola, soybean, and walnuts 
(Roche, 1999).  
 
 
1.2. LCPUFA and human health 
 
LCPUFA generate various bioactive metabolic compounds to regulate 
inflammatory responses, play role as secondary messengers, and mediate 
functions for vascular tone and platelet aggregation, contributing to membrane 
biophysical properties and integrity and hence are indirectly associated with 
diverse chronic disease such as cardiovascular disease, diabetes, arthritis, 
and cancer (Simopoulos, 1999; Le et al., 2009). Insulin sensitivity is 
associated with phospholipid fatty acid composition (Benatti et al., 2004). Ratio 
of n-6/n-3 fatty acids affects cell adhesion and invasion-related gene 
expression in human lung cancer cells (Xia et al., 2005). Many epidemiological 
and clinical studies imply that n-3 fatty acids affect on the arrhythmic action of 
patients with coronary heart disease (Benatti et al., 2004). 
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Eicosanoids generated from n-6 and n-3 fatty acids have pro-inflammatory and 
anti-inflammatory activities, respectively (Lee et al., 1984). EPA has been 
reported to be a precursor of resolvin E1, a mediator that reduces the 
inflammatory response through the regulation of leukocyte extravasation 
(Serhan et al., 2002; Dona et al., 2008). DHA is a precursor of neuroprotectin 
D1, which is a lipid mediator to protect neurons and retinal cells under 
oxidative stress conditions (Mukherjee et al., 2004). EPA and DHA inhibit the 
production of eicosanoids from ARA, producing eicosanoids from EPA and of 
anti-inflammatory resolvins and similar metabolic regulators from DHA. The 
eicosanoid syntheses are regulated by COX and 5-lipooxygenase pathways 
(Le et al., 2009). In addition, n-3 LCPUFA act on other pro-inflammatory 
responses such as reducing leukocyte chemotaxis, adhesion molecule 
expression and inflammatory cytokine production (Calder, 2008). These anti-
inflammatory effects were processed via pro-inflammatory transcription factor 
NF-κB and probably via activation of anti-inflammatory transcription factor 
PPAR-γ (peroxisome proliferator-activator receptor γ) (Calder, 2008).  
 
In the vertebrate central nervous system (CNS), ARA and DHA are prevalent 
fatty acids and have critical roles for brain function, neuronal development, 
and cognitive function (Brenna and Diau, 2007). These fatty acids are major 
constituents of brain membranes, and studies indicated the importance of 
DHA in neurogenesis (Calderon and Kim, 2004; Cao et al., 2005), 
neurotransmission (Chalon, 2006), and protection against oxidative stress 
(Bazan, 2006). Recent genome wide expression studies have shown that 
dietary DHA and ARA changes expression of thousands of genes in the brain, 
and liver tissues (Kitajka et al., 2004; Berger et al., 2006; Kothapalli et al., 
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2007). Our own recent studies have shown that CNS DHA is regulated by 
dietary DHA through modulation of biosynthesis, however, that of CNS ARA is 
mediated depending on the level of incorporation or utilization (Brenna and 
Diau, 2007; Hsieh and Brenna, 2009). In addition to brain, rod outer segments 
of retina also consist of high concentration of DHA.  The function of DHA is 
also very important for visual capability (Benolken et al., 1973).  
 
 
 1.3. Synthetic pathway of LCPUFA  
 
Figure 1.1 shows the widely accepted synthetic pathway in mammals before 
our recent publication. Plants are able to produce LA and ALA, dietary EFA, 
which are synthesized by ∆15- and ∆12- desaturation from oleic acid (OA, 
18:1n-9). However, mammals have to consume EFA from plant sources and 
synthesize LCPUFA or have to directly eat LCPUFA from foods. In the 
currently accepted pathway, ∆6-desaturation is believed to be the rate-limiting 
step from LA to γ-linolenic acid (GLA, 18:3n-6). After elongation from GLA, 
dihomo-gamma-linolenic acid (DGLA, 20:3n-6) is ∆5-desaturated to ARA. With 
two consecutive elongations, another ∆6-desaturation is followed and finally β-
oxidized to docosapentaenoic acid (DPA n-6, 22:5n-6). Like the n-6 pathway, 
common enzymes catalyze desaturation and elongation for n-3 LCPUFA 
synthesis. Though there is no clear evidence in mammals regarding a ∆4-
desaturation step to form DHA, this step has been demonstrated in marine 
microorganism (Qiu et al., 2001).  
 
An alternative LCPUFA synthetic pathway via ∆8-desaturation has been  
  5
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1.  LCPUFA synthesis, as previously accepted. Two carbons of 
24 fatty acids are shortened by peroxisomal β-oxidation. D4D, D5D, D6D, and 
D8D indicate ∆4-, ∆5-, ∆6-, and ∆8-desaturases, respectively. 
 
 
 
[16:2n-6] [16:3n-3]
18:2n-6 18:3n-3
18:3n-6 18:4n-3
20:3n-6 20:4n-3
20:4n-6 20:5n-3
22:4n-6 22:5n-324:4n-6
24:5n-6 22:5n-6
24:5n-3
24:6n-322:6n-3
D6D (FADS2)
D5D (FADS1)
D6D (FADS2)
In mammals
D6D (FADS2)
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D4D
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(de novo)
Elongase
Elongase
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20:2n-6 20:3n-3
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demonstrated by molecular cloning and functional characterization in the 
unicellular organisms, in Euglena gracilis, Acanthamoeba castellanii, 
Perkinsus marinus  (Wallis and Browse, 1999; Chu et al., 2004; Sayanova et 
al., 2006). However, the existence of ∆8-desaturation has been in question 
(Chen et al., 2000) though many studies have reported the ∆8-desaturation 
activity in mammals. Schaeffer et al showed higher levels of 20:2n-6, substrate 
of ∆8-desaturation, and significantly reduced levels of 18:3n-6, substrate of 
∆6-desaturation, and higher levels of 20:3n-6, in human plasma and red cells 
in individuals homozygous for the minor alleles of several single nucleotide 
polymorphisms in FADS2 gene (Schaeffer et al., 2006).  This observation 
might be explained by the existence of ∆8-desaturation. 
 
 
1.4. Desaturases of LCPUFA 
 
Desaturases for LCPUFA are non-heme-iron-containing, membrane-bound 
enzymes that catalyze the addition of a double bond in a fatty acid chain. They 
have an N-terminal cytochrome b5 domain and 3 histidine motifs (HX3-4H, HX2-
3HH, and H/QX2-3HH) (Nakamura and Nara, 2004). On human choromosome 
11 (11q12-13.1), fatty acid desaturase (FADS) genes consisting of FADS1, 
FADS2, and FADS3 are clustered within a 100 kb region (Marquardt et al., 
2000) (Figure 1.2). The mouse homologues of these genes are located on 
chromosome 19 as a cluster (Nakamura and Nara, 2004). All three desaturase 
genes contain the same 12 exons and 11 introns; FADS1 and 2 putative 
proteins consist of 444 amino acids which is different from FADS3 that is 
comprised of a 445 amino acid protein. The location of desaturase genes 
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suggested that the genes are thought to have arisen by gene duplication 
during the evolution (Marquardt et al., 2000).  
 
The FADS1 gene product is known as the ∆5-desaturase.  It introduces a 
double bond in last step of the production of ARA and EPA from DGLA and 
20:4n-3, respectively (Cho et al., 1999a). The FADS2 gene product catalyzes 
the introduction of a ∆6 double bond from LA to GLA and ALA to stearidonic 
acid (18:4n-3) (Cho et al., 1999b). In addition to the desaturation of palmitic 
acid (16:0) (Ge et al., 2003; Guillou et al., 2003), FADS2 gene product 
catalyzes ∆6-desaturation from 24:4n-6 to 24:5n-6 and from 24:5n-3 to 24:6n-
3 (D'Andrea et al., 2002).  The activity of FADS3 gene product remains still 
unknown, though the first report of the gene was in 2000 (Marquardt et al., 
2000). Apart from mammals, the zebrafish desaturase contain both ∆5- and 
∆6- desaturation activities (Hastings et al., 2001) and Caenorhabditis elegans 
omega-3 desaturase (FAT-1) catalyzes a change from n-6 fatty acids to n-3 
fatty acids by introducing a double bond between 3rd and 4th carbons from the 
methyl end of a fatty acid chain (Spychalla et al., 1997). 
 
Recently, reports of FADS2 deficient (FADS2 -/-) mice suggested the 
physiological roles in vivo. FADS2 deficiency did not affect the viability and 
development of mice, independent of the support of LCPUFA, but the 
deficiency induced the reproductive abnormality and sterility of mice (Stoffel et 
al., 2008; Stroud et al., 2009). Stroud et al. also reported that FADS2 -/- mice 
displayed  dermatitis and the symptoms disappeared after the 
supplementation of ARA and that FADS2 -/- mice created the ulceration of the 
small intestine (Stroud et al., 2009). Interestingly, Stroud et al. showed that  
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Figure 1.2.  The localization of FADS1, FADS2, and FADS3 on human 
chromosome 11. FADS1; fatty acid desaturase 1, FADS2; fatty acid 
desaturase 2, FADS3; fatty acid desaturase 3, FTH1; ferritin-heavy chain 1. 
 
 
 
 
 
 
 
 
FADS1 (D5D) FADS2 (D6D) FADS3 FTH1
Human chromosome 11
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FADS2 -/- mice caused the high expression of FADS3 compared to FADS2 
+/+ mice, implying a role for FADS3 in LCPUFA synthesis (Stroud et al., 
2009).  
 
 
1.5. FADS gene clusters and human health 
 
Recent studies have suggested the importance of FADS genes for human 
health and cognitive development based on genome wide analyses. They 
show associations between fatty acid genes and various physiological 
conditions. An early first report about the relationship between fatty acid 
composition in phospholipid and FADS gene clusters, Schaeffer et al. 2006 
showed that PUFA compositional changes in serum phospholipids are 
associated with FADS1 FADS2 gene clusters and ARA is most significantly 
associated with the genetic variants (Schaeffer et al., 2006). Another study 
showed that genetic variants in FADS gene cluster of patients with 
cardiovascular disease are associated with ARA, the precursor for 
proinflammatory eicosanoids (Malerba et al., 2008). These studies suggest 
that the genetic variation within FADS genes may have important roles for 
inflammatory related diseases and that the genotypes may be critical 
modulators of desaturase activities (Lattka et al., 2009). A recent genome wide 
study also suggests that enzymes for LCPUFA synthesis, specifically 
desaturases and elongases, influence concentrations of plasma fatty acid 
(Tanaka et al., 2009).  
 
As physiological and cognitive studies, FADS gene clusters were investigated. 
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FADS1 and FADS2 SNP (single nucleotide polymorphism) affects plasma and 
erythrocyte phospholipids and breast milk fatty acid compositions in pregnancy 
and lactation. Those SNP may have effects on the DHA, in maternal breast 
milk, essential for infant development (Xie and Innis, 2008). Caspi et al 
showed that a genetic variant of FADS2 is associated with IQ and 
breastfeeding (Caspi et al., 2007), though the SNP in question was within an 
intron. Additionally, ADHD (Attention Deficit/Hyperactivity Disorder), one of the 
most usual and heritable behavioral disorders in childhood, was analyzed with 
genetic variants within FADS genes showing that a single SNP within FADS2 
is highly associated with ADHA (Brookes et al., 2006).  
 
 
1.6. Regulation of desaturases in LCPUFA  
 
Dietary LCPUFA inhibits the expression of ∆5- and ∆6-desaturases by 
feedback regulation (Nakamura and Nara, 2004). Sterol regulatory element 
binding protein-1c (SREBP-1c) and peroxisome proliferator activated receptor-
α (PPARα) have been reported as regulators of the desaturases. SREBP-1c 
and PPARα are transcription factors for fatty acid synthesis and for fatty acid 
oxidation, respectively (Nakamura and Nara, 2004), but both of them were 
known to induce the expression of mice ∆5- and ∆6-desaturase genes in liver 
(Matsuzaka et al., 2002; Nakamura and Nara, 2004). Nara et al also identified 
the 90-bp promoter region of FADS2 gene which is not only required for the 
activation of the gene by SREBP-1c but for the suppression of FADS2 gene by 
LCPUFA (Nara et al., 2002).  
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In addition, both ∆5- and ∆6-desaturses are regulated by various hormones.  
Insulin activates both enzymes, but glucagon, adrenaline, glucocorticoids, 
mineralocorticoids, oestriol, oestradiol, testosterone, and ACTH suppress both 
enzymes (Brenner, 2003). Previous studies showed that proportions of ARA 
and EPA in liver were reduced by insulin-dependent diabetes, however insulin 
increased these fatty acids. Interestingly, DHA displayed the opposite; an 
increase in liver DHA is associated in insulin-dependent diabetes (Hu et al., 
1994; Chanussot et al., 1997; Brenner et al., 2000; Brenner, 2003). These 
results imply that the enzymes for synthesis for DHA are not affected by 
insulin or the biosynthesis for DHA could be different from ARA and EPA. 
 
 
1.7. Elongases of LCPUFA 
 
Elongases, or fatty acid chain elongation system (FACES), are the enzymes 
which catalyze an increase in chain length by adding two carbons to the 
carboxyl end group of a fatty acid chain. FACES consists of four enzyme units, 
condensing enzyme, β-ketoacyl CoA reductase, β-hydroxyacyl CoA 
dehydrase, and trans-2-enoyl CoA reductase (Leonard et al., 2004; Jakobsson 
et al., 2006), whereas the elongase is the first condensing enzyme. The 
elongases are generally able to be classified depending on the degree of 
unsaturation and the chain length.  Human ELOVL2, 4, and 5 genes encode 
for enzymes mediating elongation of PUFA. The ELOVL2 gene product, 
consisting of 296 amino acids, has elongation activity for C20 and C22 PUFA 
(Leonard et al., 2004).  The ELOVL4 gene product, encoding for 314 amino 
acids, is highly expressed in retina, brain, and testis (Leonard et al., 2002), 
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which suggests that it might be related to the synthesis of DHA. The ELOVL5 
gene product encodes for 299 amino acids and elongates C18-C20 PUFA 
(Leonard et al., 2004; Jakobsson et al., 2006). Additionally, mouse Elovl2 
showed activity against DGLA to some degree, however, human ELOVL2 was 
not able to elongate the fatty acid, suggesting that there is a functional 
divergence between species. ELOVL genes in the ER are also thought to 
have a function in the biosynthesis of PPARα ligands for the synthesis of 22-
carbon fatty acids (Jakobsson et al., 2006), but further study is still required on 
this point.   
 
 
1.8. Alternative splicing 
 
Alternative splicing (AS) has been identified to be critical in molecular and 
cellular mechanisms. Recent studies show that AS occurs in more than 95% 
of human multiexon genes (Calarco et al., 2009). AS events can be divided 
into several splicing patterns such as exon skipping, alternative 5’ splice sites, 
alternative 3’ splice sites, and retained introns (Stamm et al., 2005). By diverse 
combination of splicing patterns, many transcripts and isoforms can be 
generated. For instance, the human neurexin3 gene is able to generate more 
than 1700 transcripts, and Drosophila Down syndrome cell adhesion molecule 
(DSCAM) is able to form over 38,000 proteins by alternative splicing (Celotto 
and Graveley, 2001).  
 
AS mediates gene expression and contributes to protein diversity by 
generating a number of mRNA and protein isoforms from the low number of 
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eukaryotic genes (Black, 2000; Graveley, 2001). It also has an effect on the 
structure of mRNA and their protein.  These effects are capable of changing 
the features of protein functions: binding properties, enzyme activity, 
intracellular localization, protein stability, phosphorylation, and glycosylation 
patterns (Stamm et al., 2005). Though AS has been reported in various 
tissues, the most prevalent regulatory tissues for this event are in the brain 
and nervous system for functions such as synaptogenesis, neurite outgrowth, 
axon guidance, ion channel activity, and long-term potentiation (Calarco et al., 
2009). For example, DSCAM is crucial in the development of neural circuitry 
and in dendritic self-avoidance, in which only a few different amino acids 
serves to identify one neuron from another. Fibroblast growth factor 8 (FGF8), 
regulating of vertebrate midbrain development, has two isoforms showing very 
different activities depending on the development (Li et al., 2007).  
 
 
1.9. Summary 
 
Long chain polyunsaturated fatty acids (LCPUFA) are critical for human health 
and cognition development as well as are associated with eicosanoid signaling 
and membrane biophysical properties. The synthesis of LCPUFA is generally 
believed to be regulated by ∆5- and ∆6-desaturases, elongases, and two 
carbon shortening β-oxidation. However, previous studies have also 
suggested the existence of the alternative pathway via ∆8-desaturation in 
LCPUFA synthesis. Herein, we hypothesized that FADS2 gene product would 
show ∆8-desaturation activity and the report that we have recently published 
reveals that FADS2 gene product is a ∆8-desaturase as well as ∆6-desaturase  
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Figure 1.3.  LCPUFA synthesis, as currently accepted. Two carbons of 24 
fatty acids are shortened by peroxisomal β-oxidation. D4D, D5D, D6D, and 
D8D indicate ∆4-, ∆5-, ∆6-, and ∆8-desaturases, respectively. 
 
 
 
 
18:3n-6
Elongase
[16:2n-6] [16:3n-3]
18:2n-6 18:3n-3
18:4n-3
20:3n-6 20:4n-3
20:4n-6 20:5n-3
22:4n-6 22:5n-324:4n-6
24:5n-6 22:5n-6
24:5n-3
24:6n-322:6n-3
D6D (FADS2)
D5D (FADS1)
D6D (FADS2)
In mammals
D6D (FADS2)
In mammals
D4D
In marine orgnamism
(de novo)
Elongase
Elongase
Elongase
20:2n-6 20:3n-3
Elongase
D8D 
(FADS2) 
D8D 
(FADS2) 
  15
(Park et al., 2009a). Figure 1.3 shows a refinement of the accepted LCPUFA 
pathway modified after our recent publication. 
 
On the long arm of human chromosome 11, FADS1, FADS2, and FADS3 are 
localized within a 100 kb region. The functions of these genes as well as the 
association between FADS genes and physiological conditions have been 
studied. In addition, the regulatory mechanisms of desaturases by 
transcription factors and various hormones have been reported. However, 
there was no clear report about AT of fatty acid desaturase genes involved in 
LCPUFA synthesis although importance of AS has been increasing in 
molecular mechanisms. We reported here the existence of AT for FADS2 and 
FADS3 generated by AS events.  Functional characterization of these AT may 
provide clues to understanding LCPUFA synthetic regulation (Park et al., 
2009b; Park et al., 2009c). 
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CHAPTER 2 
 
AN ALTERNATE PATHWAY TO LONG CHAIN POLYUNSATURATES 
:  THE FADS2 GENE PRODUCT ∆8-DESATURATES 20:2N-6 AND 20:3N-31  
 
 
2.1. Introduction 
 
Long chain polyunsaturated fatty acids (LCPUFA) are ubiquitous in 
mammalian tissue, achieving highest concentrations in the membranes of 
neural and other excitable tissue (Brenna and Diau, 2007).  LCPUFA of the n-
3 and n-6 families, especially eicosapentaenoic acid (EPA; 20:5n-3), 
docosahexaenoic acid (DHA; 22:6n-3) and arachidonic acid (ARA; 20:4n-6) 
are bioactive components of membrane phospholipids and serve as 
substrates for signaling molecules (Kinsella et al., 1990).  The degree of 
unsaturation of the membranes is determined by the action of enzymes 
involved in fatty acid biosynthesis and metabolism (Voss et al., 1991).  Most 
organisms synthesize unsaturated fatty acids, but the pathways are specific to 
cell types and species.   
 
Fatty acid desaturases are enzymes that catalyze the introduction of cis 
double bonds at specific positions in a fatty acid chain (Los and Murata, 1998).  
Desaturases in plants and lower animal species can introduce double bonds 
near the methyl end.  Eukaryotic cells of higher animals, fungi, and 
dinoflagellates express membrane bound acyl-CoA front end desaturases 
(Tocher et al., 1998; Nakamura and Nara, 2004) catalyzing double bond 
                                                 
1 Based on the reference of J. Lipid Res. 2009 Jun;50(6):1195-202. 
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introduction into the ∆6, ∆5, ∆8, and ∆4 positions. Mammalian front end 
desaturases operate on diet-derived PUFA to synthesize LCPUFA, which can 
also be derived from the diet but possibly  not in sufficient quantities to 
optimize health (Salem et al., 1996).   
 
The front end desaturases are remarkable for their structural similarity and 
functional diversity. They all contain the N-terminal cytochrome b5 domain 
(HPGG) as electron donor and three histidine motifs “HXXXH, HXXHH and 
QXXHH” conserved from human to microalgae (Sperling et al., 2003). 
Molecular cloning and isolation of a ∆5-desaturase from Caenorhabditis 
elegans (Michaelson et al., 1998b), Mortierella alpina (Michaelson et al., 
1998a) and a ∆6-desaturase from C. elegans (Napier et al., 1998), M. alpina 
(Huang et al., 1999), rat (Aki et al., 1999), and mouse (Cho et al., 1999b) have 
all been reported.  The human FADS gene cluster at 11q12-q13.1 encodes 
two desaturases with known function, ∆5-desaturase (FADS1) and ∆6-
desaturase (FADS2) (Cho et al., 1999a; Cho et al., 1999b), as well as a third 
putative desaturase gene (FADS3) (Marquardt et al., 2000) which thus far has 
no known substrate despite high homology to FADS1 and FADS2.   
 
Figure 2.1 shows the common n-3 and n-6 LCPUFA pathways mediated by ∆6 
and ∆5 desaturases. The ∆6-desaturase (FADS2) is known to operate on both 
18:3n-3 and 18:2n-6, resulting in the synthesis of 6,9,12,15-18:4 and 6,9,12-
18:3 (gamma-linolenic acid), respectively.  This step is rate-limiting, and is 
followed by elongation to 8,11,14,17-20:4 and 8,11,14-20:3 (dihomo-gamma-
linolenic acid).  A rapid ∆5-desaturation (FADS1) on these PUFA produces 
EPA and ARA.  EPA can be further elongated and desaturated to yield DHA  
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Figure 2.1.  Pathways for LCPUFA Biosynthesis.   
Conventional pathway consists of alternating desaturation and elongation 
leading to LCPUFA.  ∆8-Desaturation of 20:2n-6 and 20:3n-3 would yield 
20:3n-6 and 20:4n-3, intermediates in the conventional pathway to 20:4n-6 
and 20:5n-3 as well as immediate eicosanoid precursors. 
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by the pathway shown, which is accepted as mammalian pathway, or via a 
∆4-desaturase as demonstrated in Thraustochytrium (Qiu et al., 2001).  
 
The operation of an alternative pathway via C20 fatty acids using a ∆8-
desaturase reported in unicellular organisms (Korn, 1964b; Korn, 1964a; Lees 
and Korn, 1966; Qi et al., 2002), has been verified by molecular cloning and 
functional characterization studies in Euglena gracilis (Wallis and Browse, 
1999), Acanthamoeba castellanii (Sayanova et al., 2006), and Perkinsus 
marinus (Chu et al., 2004). There are many reports of ∆8-desaturation activity 
in mammalian cells (Nakazawa et al., 1976; Bardon et al., 1996), rat and 
human testes (Albert and Coniglio, 1977; Albert et al., 1979), and in mouse 
liver (Schenck et al., 1996), though it has not been verified by molecular 
cloning and the existence of ∆8-desaturation in rat microsomes has been 
questioned (Chen et al., 2000).  The putative substrate of the ∆8-desaturase, 
11,14-eicosadienoic acid (20:2 n-6), is found in human plasma and red cells 
as well as other tissues, and its concentration has recently been associated 
with human genetic variation in the FADS gene cluster (Schaeffer et al., 2006; 
Malerba et al., 2008). 
 
The mammalian ∆6-desaturase coded by FADS2 uses at least 5 substrates, 
18:2n-6, 18:3n-3, 24:6n-3, 24:5n-3, (D'Andrea et al., 2002; Guillou et al., 2003) 
and 16:0.  ∆6-desaturase in the sebaceous glands catalyzes desaturation of 
16:0 to 16:1n-10 (sapienate), the most abundant fatty acid in human sebum, 
showing that substrate specificity is influenced by the cellular environment in 
which it is expressed (Ge et al., 2003).  We hypothesized that the primate 
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FADS2 gene product would have ∆8-desaturase activity and cloned baboon 
FADS2 into Saccharomyces cerevisiae, an organism with no native PUFA 
biosynthetic capability, to test for gain of ∆8-desaturation activity.  Here we 
report unambiguous evidence of the existence of ∆8-desaturation in primates, 
suggesting alternative pathway for LCPUFA biosynthesis. 
 
 
2.2. Materials and methods 
 
RNA isolation and cDNA synthesis 
Total RNA from 30 mg neonate baboon liver tissue homogenate was extracted 
using the RNeasy Mini kit (Qiagen, Valencia, CA). The yield of total RNA was 
assessed by 260 nm UV absorption. The quality of RNA was analyzed by 
260/280 nm ratios of the samples and by agarose gel electrophoresis to verify 
RNA integrity. One microgram total RNA was reverse-transcribed into first 
strand cDNA using the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA). 
The resulting cDNA was used as template for RT-PCR reactions. 
 
Cloning of baboon FADS2 and sequence analysis 
In order to identify baboon FADS2 cDNA sequence, primers were generated 
using human cDNA sequences for FADS2 (Gen Bank Acc# NM_004265). 
PCR primers, FADS2- Forward (5’- ATG GGG AAG GGA GGG AAC CAG 
GGC GA -3’) and FADS2- Reverse (5’- TCA TTT GTG AAG GTA GGC GTC 
CAG CCA -3’) were ordered from Integrated DNA Technologies (IDT, 
Coralville, IA) and were amplified with baboon liver cDNA as template and 
high-fidelity Taq polymerase (Roche Diagnostics Ltd) using Eppendorf 
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gradient thermal cycler.  Cycling conditions were: initial denaturation at 95°C 
for 5 min followed by 40 cycles of denaturation at 95°C for 30 s, annealing at 
72°C for 45 s and extension at 72°C for 1 min, with a final extension at 72°C 
for 5 min. PCR product was separated by electrophoresis on 2% agarose gel 
stained with ethidium bromide and band of appropriate size was obtained. The 
PCR product was gel purified and cloned in pGEM T-Easy vector (Promega, 
USA) and sequenced using T7 forward and SP6 reverse universal primers at 
Cornell University Life Sciences Core Laboratories Center using the Applied 
Biosystems automated 3730 DNA analyzer. We have successfully cloned 
baboon FADS2 protein coding region (GenBank Acc#EU780003).  The pGEM 
T- Easy vector with FADS2 was named pTFADS2. 
 
Transformation into yeast (Saccharomyces cerevisiae) 
The entire coding regions of baboon FADS2 was amplified from pTFADS2 
with primers FADS2-KOZAK-Forward (5’- CCC AAG CTT ACC ATG GGG 
AAG GGA GGG AAC CAG GGC GA -3’) including HindIII site and FADS2-
KOZAK-Reverse (5’- CCG CTC GAG TCA TTT GTG AAG GTA GGC GTC 
CAG CCA -3’) including XhoI site.  The high fidelity Taq polymerase (Roche 
Diagnostics Ltd.) was used to minimize potential PCR errors. The amplified 
PCR product containing baboon FADS2 was gel purified, restriction digested 
and inserted into HindIII and XhoI sites behind the GAL1 promoter of pYES2 
vector (Invitrogen, USA) to yield the plasmid pYFADS2. The constructed 
plasmid of pYFADS2, was transformed into S. cerevisiase (strain INVSc1 from 
Invitrogen, USA) using S. c. Easy CompTM Transformation Kit (Invitrogen), and 
the transformants were verified by DNA sequencing. 
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Expression of baboon FADS2 
For functional expression characterization, transformed yeast strains with 
pYES2 (empty vector) as a negative control and pYFADS2 were grown for 24h 
in S. cerevisiae minimal media without uracil. As another negative control, wild 
S. cerevisiae (INVSc1) was cultured in S. cerevisiae minimal medium with 
uracil. Expression of the transgene was induced when OD600 reached 0.4. At 
that time, appropriate fatty acids, 1mM linoleic acid (18:2n-6), alpha-linolenic 
acid (18:3n-3), eicosadienoic acid (20:2n-6), eicosatrienoic acid (20:3n-3) were 
added in the presence of 1% tergitol-Nonidet P-40 (Sigma, USA) to the 
cultures and were grown at 30oC with constant shaking. The samples were 
collected after 48h for fatty acid analysis.  All treatments were performed in 
duplicate. 
 
Fatty acid analysis 
The yeast cells were harvested by centrifugation at 4,000 rpm for 5 min. The 
cell pellets were washed twice with tergitol-Nonidet P-40 and finally twice with 
distilled water. Fatty acid methyl esters (FAME) were prepared by using 
modified one-step lipid extraction method of Garces and Mancha (Garces and 
Mancha, 1993). FAME were structurally identified by GC-CACI-MS/MS (Van 
Pelt and Brenna, 1999; Michaud et al., 2002; Lawrence and Brenna, 2006) 
and quantitatively analyzed by GC-FID.  An equal weight FAME mixture was 
used to verify response factors on a daily basis (Diau et al., 2005).  For 
competition experiments, GC analyses were performed in triplicate. 
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Materials (Chemicals) 
Fatty acids (18:2n-6, 18:3n-3, 20:2n-6 and 20:3n-3) were purchased from Nu-
Chek Prep, Inc, MN, USA. Uracil drop out SD-U medium and supplement 
contents including amino acids were obtained from Clontech, TaKaRa Bio, 
USA. Uracil and tergitol NP-40 was from Sigma-Aldrich, USA. pGEM-T Easy 
Vector II system was purchased from Promega Corporation, WI, USA. The 
pYES2 vector, INVSc1 strain, S. c. Easy CompTM Transformation Kit, and 
restriction enzymes (HindIII and XhoI) were obtained from Invitrogen, USA. 
Total RNA was isolated by using RNeasy Mini kit from Qiagen, CA, USA.  
cDNA synthesis kit was purchased from Bio-Rad, USA.  
 
 
2.3. Results 
 
Baboon fatty acid desaturase 2 (FADS2): 
The sequenced PCR product (Baboon FADS2; GenBank EU780003) revealed 
an open reading frame of 1,335 base pairs, encoding a protein of 444 amino 
acids and a stop codon. It shares a 60% homology with baboon FADS1 
(EF531577) and 62% homology with the putative baboon FADS3 (EU780002), 
including “HPGG” characteristic of a cytochrome b5 domain and three 
conserved histidine motifs “HXXXH, HXXHH and QXXHH”.  Analysis and 
comparison of amino acid sequence of baboon FADS2 showed 97% identity 
and 99% similarity with human FADS2 (AAH09011), and 64% identity and 
79% similarity with the bifunctional zebrafish desaturase (AAG25710). Baboon 
FADS2 also shares homology with ∆8-desaturases from unicellular organisms 
  33
(27% identity and 43% similarity with E. gracilis (AAD45877), 27% identity and 
40% similarity with P. marinus (ABF58684), and 23% identity and 38% 
similarity with A. castellanii (CAO00489)). Analysis of the baboon FADS2 
secondary structure by SOSUI software <http://bp.nuap.nagoya-
u.ac.jp/sosui/> (Hirokawa et al., 1998) predicted three transmembrane 
regions, whereas baboon FADS1 and the putative baboon FADS3 had four 
transmembrane regions (data not shown). 
 
The transformed yeast grown on minimal media were supplemented with 
various fatty acids, incubated at 30°C and harvested after 48 h.  Wild type (wt) 
S. cerevisiae, and S. cerevisiae containing empty pYES2 vector were used as 
controls for every replicate. Gas chromatography-covalent adduct chemical 
ionization tandem mass spectrometry (GC-CACI-MS) chromatograms of fatty 
acid methyl ester (FAME) are presented in Figures 2.2 and 2.3 for 20:2n-6 and 
20:3n-3 incubations, respectively.  Panel A, B and C of both figures 
correspond to wt S. cerevisiae, S. cerevisiae containing empty pYES2 vector 
and S. cerevisiae containing FADS2, respectively.  S. cerevisiae wt and S. 
cerevisiae with empty pYES2 vector have no activity toward 20:3n-6 and 
20:4n-3, as expected.  Figure 2.2, Panel C shows a new product appearing 
upon incubation with 20:2n-6.  Panel D is the MS-1 spectrum showing peaks 
at m/z 374, 321, 289, and 271, corresponding to the [M+54]+, [MH]+, [MH-32]+ 
, and [MH-32-18]+ ions, respectively, characteristic of a 20:3 FAME.  Panel E 
is the collisional dissociation spectrum of [M+54]+, yielding ions at m/z 262 and 
m/z 190 corresponding, respectively, to the α and ω diagnostic ions for 20:3n-
6 and positively identifying this product.  Similarly, Figure 2.3, panel D, 
displays MS1 ions characteristic of a 20:4 (m/z 372, 319, 287, 269), and  
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Figure 2.2. Data Showing FADS2 Action On 20:2n-6.   
(A)  Reconstructed ion chromatograms (RIC) of FAME derived from 48h 
incubation of 20:2n-6 with wildtype S. cerevisiae,  
(B)  S. cerevisiae transformed with empty vector and, 
(C)  S. cerevisiae transformed with FADS2 showing novel product.   
(D)  CACI-MS1 spectrum of novel product in C) showing diagnostic ions for a 
20:3 FAME.   
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Figure 2.3 . Data Showing FADS2 Action On 20:3n-3.  
Figure Panels are analogous to those in Figure 2, and demonstrate synthesis 
of 20:4n-3.   
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collisional dissociation yields diagnostic ions m/z 302 and 188 in MS/MS, 
positively identifying 20:4n-3.   
 
An alternative hypothesis to ∆8-desaturation of 20:2n-6 (20:2n-6 Æ 20:3n-6) is 
β-oxidation followed by entry into the normal pathway (20:2n-6 Æ 18:2n-6 Æ 
18:3n-6 Æ 20:3n-6).  Wt S. cerevisiae contain peroxisomes and mitochondria 
and thus have native β-oxidation activity, so this pathway is plausible.  Figure 
1.4a presents the relative product distribution with 18:2 as a substrate.  No 
∆6-desaturation is observed for the controls (wt or vector only), while the cells 
transformed with FADS2 accumulate 18:3n-6 and about 8% of this product is 
further elongated to 20:3n-6 (18:2n-6 Æ 18:3n-6 Æ 20:3n-6).  There is also 
some elongation of 18:2n-6 to 20:2n-6.   
 
The putative intermediate of a β-oxidation-mediated alternative pathway, 
18:3n-6, was detected in only one of two trials with 20:2n-6 used as a 
substrate.  Figure 1.4b presents relative product distribution with 20:2n-6 for 
that trial.  There is indeed some β-oxidation to 18:2n-6 in all treatments.  
However, ∆6-desaturation of this product to 18:3n-6 is detected in only the 
FADS2 cells, and is about 7% of the 18:2n-6 product.  The ∆8-desaturation 
product, 20:3n-6, is more than 10-fold greater in abundance than 18:3n-6, its 
putative intermediate in the alternative pathway.  Considering the data of 
Figure 2.4a, the conversion of 18:3n-6 Æ 20:3n-6 can only account for a 
negligible fraction of the 20:3n-6.  We conclude that ∆8-desaturation by the 
FADS2 product mediates direct conversion of 20:2n-6 to 20:3n-6. 
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Figure 2.4.  Analysis of Putative Intermediates.   
(A)  Peak areas of n-6 PUFA, normalized to 20:0, for wt, vector-only, and 
FADS2 transformed cells treated with 18:2n-6.  A small amount of chain-
shortening is detected (16:2n-6) in wt and FADS2 cells.  The FADS2 cells 
uniquely show accumulation of the ∆6-desaturated product 18:3n-6, the 
elongated product 20:2n-6, and a small amount of 20:3n-6, the chain 
elongated product of 18:3n-6. 
(B)  All 20:2n-6 treated cells show the chain shortened product 18:2n-6, and 
only the FADS2 cells show a small amount of the elongated product 18:3n-6.  
The product of ∆8-desaturase activity on 20:2n-6, 20:3n-6, is present only in 
the FADS2 cells at about 10-fold higher concentration than 18:3n-6.  
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Once establishing that FADS2-transformed S. cerevisiae gained the ability to 
∆8-desaturate 20-carbon PUFA, the relative activity was tested in competition 
experiments.  ∆8-desaturase activity toward n-3 and n-6 fatty acids was 
investigated by supplementing media with a 1:1 mixture of 20:2n-6 and 20:3n-
3 as substrates.  Substrates and products were analyzed quantitatively by gas 
chromatography-flame ionization detector (GC-FID) after confirmation of 
structure by GC-CACI-MS and GC-CACI-MS/MS.  Table 1.1 shows that 20:2n-
6 Æ 20:3n-6 was 0.9±0.16% and 20:3n-3 Æ 20:4n-3 was 2.8±0.7% over a 48 
h incubation, yielding a relative conversion efficiency of about 3.1 fold, favoring 
the n-3 PUFA. 
 
In a second competition experiment, 1:1 mixtures of 18:2n-6+20:2n-6 or 
18:3n-3+20:3n-3 were added to media to test the relative ∆6-desaturase and 
∆8-desaturase activities.  Table 1.2 shows that conversions 18:2n-6 Æ 18:3n-
6 and 20:2 n-6 Æ 20:3n-6 were 12.2±0.16% and 1.7±0.54% respectively, 
yielding a relative activity of 7.2-fold favoring ∆6-desaturase.  The relative 
conversions 18:3n-3 Æ18:4n-3 and 20:3n-3 Æ 20:4n-3 were 24.1±2.4% and 
1.03±0.31% respectively, yielding the substantially greater conversion ratio of 
23. 
 
 
2.4. Discussion 
 
More than 50 years ago, Thomasson showed that the n-6 PUFA were active in 
supporting growth of water deprived young rats raised on a diet with saturates 
as their only source of fat.  The order of relative "vitamin F" activity was  
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Table 2.1. Competition between n-6 and n-3 fatty acids 
                         
 
Substrate 
Mixture 
Reactions 
Conversion of 
substrate (%) 
Mean ± SD 
Ratio
∆8-desaturase 
20:2n-6 Æ 
20:3n-6 
0.90±0.16 
20:2n-6+ 
20:3n-3 ∆8-desaturase  
20:3n-3 Æ 
20:4n-3 
2.8±0.7 
3.1 
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Table 2.2. Competition between ∆6- and ∆8-desaturase activities  
 
 
Substrate 
Mixture 
Reactions 
Conversion of 
substrate (%) 
Mean ± SD 
Ratio
∆6-desaturase 
18:2n-6 
Æ18:3n-6 
 
12.2±0.16 
18:2n-6+ 
20:2n-6 ∆8-desaturase 
20:2n-6 Æ 
20:3n-6 
 
1.7±0.54 
7.2 
∆6-desaturase  
18:3n-3 Æ 
18:4n-3 
 
24.1±2.4 
18:3n-3+ 
20:3n-3 ∆8-desaturase 
20:3n-3 Æ 
20:4n-3 
 
1.03±0.31 
23 
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20:4>18:2=20:3>20:2 (131:100:100:43), with relative activity of less than 10 
for all other fatty acids tested, including n-3s (Thomasson, 1953).  Within two 
decades, the pathway from 18:2 to 20:4 by sequential ∆6-desaturation-
elongation-∆5-desaturation (18:2 Æ  18:3 Æ 20:3 Æ 20:4) emerged as the 
major route of biosynthesis.  The alternative, elongation-∆8-desaturation-∆5-
desaturation (18:2 Æ 20:2 Æ 20:3 Æ 20:4), has been of interest over the years 
because of the appearance of intermediates in mammalian tissue, as has a 
third alternative, elongation-∆5-desaturation-∆8-desaturation (18:2 Æ 20:2 Æ 
5,11,14-20:3 Æ 20:4) because 20:2 is converted to 5,11,14-20:3 (sciadonic 
acid) by the action of ∆5-desaturase.  Experiments involving only activity 
measurements in mammalian tissue or cells that definitively establish or rule 
out participation of a ∆8-desaturase are difficult to design because of the low 
concentration of the intermediates, indicating that molecular techniques 
capable of isolating a particular biochemical activity are required (Chen et al., 
2000).  Indeed, the existence of ∆8-desaturation as an alternative pathway to 
LCPUFA has been reported periodically, and ∆8-desaturase activity has been 
found by some and not by others (Chen et al., 2000).  Presently, 20:2n-6 and 
20:3n-3 are widely considered dead-end products, in part because their 
conversion to LCPUFA has not been unequivocally established (Stubhaug et 
al., 2005).  However, recent studies have associated 20:2n-2 with FADS2 
polymorphisms and/or fatty acid compositions in humans (Schaeffer et al., 
2006; Rzehak et al., 2008), including patients with cardiovascular disease 
(Malerba et al., 2008) and type 2 diabetes mellitus (Kusunoki et al., 2007).  In 
addition, apoD knockout mice, a model for psychiatric disorders, show 
increased CNS 20:2n-6 and 18:2n-6 compared to wild type mice (Thomas and 
Yao, 2007).   
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Several fatty acids of chain length 16, 18, and 24 carbons are substrates for 
the FADS2 gene product.  Apart from 18:2n-6 and 18:3n-3, it is also known to 
∆6-desaturate 24:5n-3 and 24:4n-6, as required for the coupled microsomal-
peroxisomal pathway for 22:6n-3 and 22:5n-6 biosynthesis (D'Andrea et al., 
2002).   The FADS2 gene product catalyzes the ∆6-desaturation of 16:0 
(palmitic acid) to 16:1n-10 (cis-6-16:1, sapienic acid) when expressed natively 
in human skin sebocytes (Ge et al., 2003), and when COS-7 cells were 
transfected with rat FADS2 they acquired the ability to ∆6-desaturate 16:0 
(Guillou et al., 2003).   There are, however, no previous reports of FADS2 
gene product activity toward 20 carbon PUFA.   
 
The alternative synthetic pathways to arachidonic acid from 20:2n-6 are either 
by sequential action of a ∆8-desaturase and a ∆5-desaturase, or vice versa.  
Initial ∆8-desaturation yields the eicosanoid precursor 20:3n-6, whereas initial 
∆5-desaturase activity yields 5,11,14-20:3. There are numerous reports 
showing that 11,14-20:2 is ∆5-desaturated to 5,11,14-20:3 (Takagi, 1965; 
Ullman and Sprecher, 1971; Sprecher and Lee, 1975; Naval et al., 1993; Chen 
et al., 2000).  However, no clear evidence for the conversion of 5,11,14-20:3 to 
20:4n-6 has been found (Ullman and Sprecher, 1971; Sprecher and Lee, 
1975; Chen et al., 2000).  Sprecher and coworkers have studied the 
desaturation of 11,14-20:2 with isotope labeling in vitro and in vivo, and 
consistently find that rat liver does ∆5-desaturate it to 5,11,14-20:3, but they 
find no evidence of ∆8-desaturation activity on this product (Ullman and 
Sprecher, 1971; Sprecher and Lee, 1975).  Fourteen day feeding of 5,11,14-
20:3 led to the accumulation of this PUFA in liver phosphoglycerides where it 
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decreased 20:4n-6, while feeding of 11,14-20:2 did not alter 20:4n-6 levels 
(Chen et al., 2000).  The production of 5,11,14-20:3 and 5,11,14,17-20:4 in 
human leukemia K562 cells has been reported in which the ∆5-desaturase is 
the only active desaturase operating because of the lack of ∆6-desaturase 
activity in these cells (Naval et al., 1993).  Consistent with this report, we 
recently found significant amounts of 7,11,14-20:3, 7,11,14,17-20:4, and 
9,13,16,19-22:4 in the liver lipids of chow-fed FADS2 null mice, all of which 
may be synthesized by action of ∆5-desaturase, coded by FADS1, on 18:2n-6 
or 18:3n-3, followed by prompt elongation (Stroud, Lawrence, Brenna, 
Nakamura, 2008, unpublished observations).  These data support the 
hypothesis that the ∆5-desaturase acts on PUFA only when its preferred 
substrate is not available, which may well imply that its products found in 
experimental studies are not relevant in vivo under normal conditions. 
 
Reports of ∆8-desaturase activity in rodent and human testes have appeared 
(Albert and Coniglio, 1977; Albert et al., 1979), and the most recent study 
shows stable isotope labeling best explained by direct conversion of 11,14-
20:2 to 20:4n-6 via ∆8-desaturation, albeit as a minor pathway (Chen et al., 
2000), but there are no existing molecular data to implicate a specific gene 
responsible for coding for vertebrate ∆8-desaturase activity.  ∆8-Desaturation 
has been shown unequivocally in unicellular organisms where the gene has 
been cloned and is active when expressed in Arabidopsis thaliana (Qi et al., 
2004).  A ∆8-desaturase was first reported in the single cell protist E. gracilis 
(Wallis and Browse, 1999) and later, along with a ∆9PUFA-elongase, in 
Isochrysis galbana (Qi et al., 2002) as well as the free living amoeba A. 
castellanii (Sayanova et al., 2006).  The present report is the first to show that 
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a vertebrate gene product introduces a double bond at the ∆8 position, 
demonstrating an alternative pathway to LCPUFA biosynthesis.   
 
The competition experiments provide insight as to whether ∆8-desaturase 
activity of the FADS2 protein product can be important in vivo.  The synthesis 
of 20:4n-3 dominates by 3.1-fold over 20:3n-6, consistent with long-
established observations for ∆6-desaturase preference for 18:3n-3 over 18:2n-
6 (Brenner and Peluffo, 1966; Christiansen et al., 1968; Cook et al., 1991).  
These observations are also are consistent with in vitro work showing that the 
biosynthesis of n-6 PUFA is strongly suppressed by <2% of calories of 18:3n-
3, whereas nearly 10 times as much 18:2n-6 is required to equally suppress n-
3 PUFA biosynthesis (Holman, 1998) and indicating that the affinity of the 
biosynthetic apparatus favors n-3 PUFA.  Our competition experiments (Table 
1.2) also establish that the FADS2 gene product exhibits both ∆6-desaturase 
and ∆8-desaturase activities when both substrates are available.  As 
expected, the FADS2 gene product showed higher ∆6-desaturase activity by 
acting on the 18:2n-6 substrate to generate 7-fold more product than for the 
20:2n-6.  The relative action ∆6/∆8 activity toward the n-3 was much greater, 
at 23-fold, indicating that the conventional pathway would be strongly favored 
when both substrates are available. 
 
In conclusion, baboon FADS2 gene cloned into S. cerevisiae causes gain of 
∆8-desaturase activity, in addition to coding for ∆6-desaturase activity.  
∆8-desaturase activity on 20:2n-6 leads directly to 20:3n-6, the immediate 
precursor of PGE1 and of 20:4n-6.  All available evidence indicates that ∆8-
desaturation is a minor pathway, but further study may show that it becomes 
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important when there is high demand for eicosanoid synthesis such as in 
inflammation or vasodilation, particularly in situations in which specialized 
tissues require 20:3n-6 as a precursor to prostaglandins E1 and F1α, 
hydroxyeicosatrienoic acids, or thromboxane B1.  This alternative pathway to 
the eicosanoid precursors may explain data suggesting that 20:2n-6 levels are 
related to human health.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  47
REFERENCES 
 
Aki, T., Shimada, Y., Inagaki, K., Higashimoto, H., Kawamoto, S., Shigeta, S., 
Ono, K. and Suzuki, O. Molecular cloning and functional 
characterization of rat delta-6 fatty acid desaturase. Biochem Biophys 
Res Commun 255 (1999), pp. 575-9. 
Albert, D.H. and Coniglio, J.G. Metabolism of eicosa-11,14-dienoic acid in rat 
testes. Evidence for delta8-desaturase activity. Biochim Biophys Acta 
489 (1977), pp. 390-6. 
Albert, D.H., Rhamy, R.K. and Coniglio, J.G. Desaturation of eicosa-11,14-
dienoic acid in human testes. Lipids 14 (1979), pp. 498-500. 
Bardon, S., Le, M.T. and Alessandri, J.M. Metabolic conversion and growth 
effects of n-6 and n-3 polyunsaturated fatty acids in the T47D breast 
cancer cell line. Cancer Lett 99 (1996), pp. 51-8. 
Brenna, J.T. and Diau, G.Y. The influence of dietary docosahexaenoic acid 
and arachidonic acid on central nervous system polyunsaturated fatty 
acid composition. Prostaglandins Leukot Essent Fatty Acids 77 (2007), 
pp. 247-50. 
Brenner, R.R. and Peluffo, R.O. Effect of saturated and unsaturated fatty acids 
on the desaturation in vitro of palmitic, stearic, oleic, linoleic, and 
linolenic acids. J Biol Chem 241 (1966), pp. 5213-9. 
Chen, Q., Yin, F.Q. and Sprecher, H. The questionable role of a microsomal 
delta8 acyl-coA-dependent desaturase in the biosynthesis of 
polyunsaturated fatty acids. Lipids 35 (2000), pp. 871-9. 
Cho, H.P., Nakamura, M. and Clarke, S.D. Cloning, expression, and fatty acid 
regulation of the human delta-5 desaturase. J Biol Chem 274 (1999a), 
  48
pp. 37335-9. 
Cho, H.P., Nakamura, M.T. and Clarke, S.D. Cloning, expression, and 
nutritional regulation of the mammalian Delta-6 desaturase. J Biol 
Chem 274 (1999b), pp. 471-7. 
Christiansen, K., Marcel, Y., Gan, M.V., Mohrhauer, H. and Holman, R.T. 
Chain elongation of alpha- and gamma-linolenic acids and the effect of 
other fatty acids on their conversion in vitro. J Biol Chem 243 (1968), 
pp. 2969-74. 
Chu, F.L., Lund, E.D., Harvey, E. and Adlof, R. Arachidonic acid synthetic 
pathways of the oyster protozoan parasite, Perkinsus marinus: 
evidence for usage of a delta-8 pathway. Mol Biochem Parasitol 133 
(2004), pp. 45-51. 
Cook, H.W., Byers, D.M., Palmer, F.B., Spence, M.W., Rakoff, H., Duval, S.M. 
and Emken, E.A. Alternate pathways in the desaturation and chain 
elongation of linolenic acid, 18:3(n-3), in cultured glioma cells. J Lipid 
Res 32 (1991), pp. 1265-73. 
D'Andrea, S., Guillou, H., Jan, S., Catheline, D., Thibault, J.N., Bouriel, M., 
Rioux, V. and Legrand, P. The same rat Delta6-desaturase not only 
acts on 18- but also on 24-carbon fatty acids in very-long-chain 
polyunsaturated fatty acid biosynthesis. Biochem J 364 (2002), pp. 49-
55. 
Diau, G.Y., Hsieh, A.T., Sarkadi-Nagy, E.A., Wijendran, V., Nathanielsz, P.W. 
and Brenna, J.T. The influence of long chain polyunsaturate 
supplementation on docosahexaenoic acid and arachidonic acid in 
baboon neonate central nervous system. BMC Med 3 (2005), p. 11. 
Garces, R. and Mancha, M. One-step lipid extraction and fatty acid methyl 
  49
esters preparation from fresh plant tissues. Anal Biochem 211 (1993), 
pp. 139-43. 
Ge, L., Gordon, J.S., Hsuan, C., Stenn, K. and Prouty, S.M. Identification of 
the delta-6 desaturase of human sebaceous glands: expression and 
enzyme activity. J Invest Dermatol 120 (2003), pp. 707-14. 
Guillou, H., Rioux, V., Catheline, D., Thibault, J.N., Bouriel, M., Jan, S., 
D'Andrea, S. and Legrand, P. Conversion of hexadecanoic acid to 
hexadecenoic acid by rat Delta 6-desaturase. J Lipid Res 44 (2003), pp. 
450-4. 
Hirokawa, T., Boon-Chieng, S. and Mitaku, S. SOSUI: classification and 
secondary structure prediction system for membrane proteins. 
Bioinformatics 14 (1998), pp. 378-9. 
Holman, R.T. The slow discovery of the importance of omega 3 essential fatty 
acids in human health. J Nutr 128 (1998), pp. 427S-433S. 
Huang, Y.S., Chaudhary, S., Thurmond, J.M., Bobik, E.G., Jr., Yuan, L., Chan, 
G.M., Kirchner, S.J., Mukerji, P. and Knutzon, D.S. Cloning of delta12- 
and delta6-desaturases from Mortierella alpina and recombinant 
production of gamma-linolenic acid in Saccharomyces cerevisiae. 
Lipids 34 (1999), pp. 649-59. 
Kinsella, J.E., Lokesh, B., Broughton, S. and Whelan, J. Dietary 
polyunsaturated fatty acids and eicosanoids: potential effects on the 
modulation of inflammatory and immune cells: an overview. Nutrition 6 
(1990), pp. 24-44; discussion 59-62. 
Korn, E.D. Biosynthesis of Unsaturated Fatty Acids in Acanthamoeba Sp. J 
Biol Chem 239 (1964a), pp. 396-400. 
Korn, E.D. The polyunsaturated 20-carbon and 22-carbon fatty acids of 
  50
Euglena. Biochem Biophys Res Commun 14 (1964b), pp. 1-6. 
Kusunoki, M., Tsutsumi, K., Nakayama, M., Kurokawa, T., Nakamura, T., 
Ogawa, H., Fukuzawa, Y., Morishita, M., Koide, T. and Miyata, T. 
Relationship between serum concentrations of saturated fatty acids and 
unsaturated fatty acids and the homeostasis model insulin resistance 
index in Japanese patients with type 2 diabetes mellitus. J Med Invest 
54 (2007), pp. 243-7. 
Lawrence, P. and Brenna, J.T. Acetonitrile covalent adduct chemical ionization 
mass spectrometry for double bond localization in non-methylene-
interrupted polyene fatty acid methyl esters. Anal Chem 78 (2006), pp. 
1312-7. 
Lees, A.M. and Korn, E.D. Metabolism of unsaturated fatty acids in protozoa. 
Biochemistry 5 (1966), pp. 1475-81. 
Los, D.A. and Murata, N. Structure and expression of fatty acid desaturases. 
Biochim Biophys Acta 1394 (1998), pp. 3-15. 
Malerba, G., Schaeffer, L., Xumerle, L., Klopp, N., Trabetti, E., Biscuola, M., 
Cavallari, U., Galavotti, R., Martinelli, N., Guarini, P., Girelli, D., Olivieri, 
O., Corrocher, R., Heinrich, J., Pignatti, P.F. and Illig, T. SNPs of the 
FADS gene cluster are associated with polyunsaturated fatty acids in a 
cohort of patients with cardiovascular disease. Lipids 43 (2008), pp. 
289-99. 
Marquardt, A., Stohr, H., White, K. and Weber, B.H. cDNA cloning, genomic 
structure, and chromosomal localization of three members of the 
human fatty acid desaturase family. Genomics 66 (2000), pp. 175-83. 
Michaelson, L.V., Lazarus, C.M., Griffiths, G., Napier, J.A. and Stobart, A.K. 
Isolation of a Delta5-fatty acid desaturase gene from Mortierella alpina. 
  51
J Biol Chem 273 (1998a), pp. 19055-9. 
Michaelson, L.V., Napier, J.A., Lewis, M., Griffiths, G., Lazarus, C.M. and 
Stobart, A.K. Functional identification of a fatty acid delta5 desaturase 
gene from Caenorhabditis elegans. FEBS Lett 439 (1998b), pp. 215-8. 
Michaud, A.L., Diau, G.Y., Abril, R. and Brenna, J.T. Double bond localization 
in minor homoallylic fatty acid methyl esters using acetonitrile chemical 
ionization tandem mass spectrometry. Anal Biochem 307 (2002), pp. 
348-60. 
Nakamura, M.T. and Nara, T.Y. Structure, function, and dietary regulation of 
delta6, delta5, and delta9 desaturases. Annu Rev Nutr 24 (2004), pp. 
345-76. 
Nakazawa, I., Mead, J.F. and Yonemoto, R.H. In vitro activity of the fatty acyl 
desaturases of human cancerous and noncancerous tissues. Lipids 11 
(1976), pp. 79-82. 
Napier, J.A., Hey, S.J., Lacey, D.J. and Shewry, P.R. Identification of a 
Caenorhabditis elegans Delta6-fatty-acid-desaturase by heterologous 
expression in Saccharomyces cerevisiae. Biochem J 330 ( Pt 2) (1998), 
pp. 611-4. 
Naval, J., Martinez-Lorenzo, M.J., Marzo, I., Desportes, P. and Pineiro, A. 
Alternative route for the biosynthesis of polyunsaturated fatty acids in 
K562 cells. Biochem J 291 ( Pt 3) (1993), pp. 841-5. 
Qi, B., Beaudoin, F., Fraser, T., Stobart, A.K., Napier, J.A. and Lazarus, C.M. 
Identification of a cDNA encoding a novel C18-Delta(9) polyunsaturated 
fatty acid-specific elongating activity from the docosahexaenoic acid 
(DHA)-producing microalga, Isochrysis galbana. FEBS Lett 510 (2002), 
pp. 159-65. 
  52
Qi, B., Fraser, T., Mugford, S., Dobson, G., Sayanova, O., Butler, J., Napier, 
J.A., Stobart, A.K. and Lazarus, C.M. Production of very long chain 
polyunsaturated omega-3 and omega-6 fatty acids in plants. Nat 
Biotechnol 22 (2004), pp. 739-45. 
Qiu, X., Hong, H. and MacKenzie, S.L. Identification of a Delta 4 fatty acid 
desaturase from Thraustochytrium sp. involved in the biosynthesis of 
docosahexanoic acid by heterologous expression in Saccharomyces 
cerevisiae and Brassica juncea. J Biol Chem 276 (2001), pp. 31561-6. 
Rzehak, P., Heinrich, J., Klopp, N., Schaeffer, L., Hoff, S., Wolfram, G., Illig, T. 
and Linseisen, J. Evidence for an association between genetic variants 
of the fatty acid desaturase 1 fatty acid desaturase 2 ( FADS1 FADS2) 
gene cluster and the fatty acid composition of erythrocyte membranes. 
Br J Nutr (2008), pp. 1-7. 
Salem, N., Jr., Wegher, B., Mena, P. and Uauy, R. Arachidonic and 
docosahexaenoic acids are biosynthesized from their 18-carbon 
precursors in human infants. Proc Natl Acad Sci U S A 93 (1996), pp. 
49-54. 
Sayanova, O., Haslam, R., Qi, B., Lazarus, C.M. and Napier, J.A. The 
alternative pathway C20 Delta8-desaturase from the non-
photosynthetic organism Acanthamoeba castellanii is an atypical 
cytochrome b5-fusion desaturase. FEBS Lett 580 (2006), pp. 1946-52. 
Schaeffer, L., Gohlke, H., Muller, M., Heid, I.M., Palmer, L.J., Kompauer, I., 
Demmelmair, H., Illig, T., Koletzko, B. and Heinrich, J. Common genetic 
variants of the FADS1 FADS2 gene cluster and their reconstructed 
haplotypes are associated with the fatty acid composition in 
phospholipids. Hum Mol Genet 15 (2006), pp. 1745-56. 
  53
Schenck, P.A., Rakoff, H. and Emken, E.A. Delta 8 desaturation in vivo of 
deuterated eicosatrienoic acid by mouse liver. Lipids 31 (1996), pp. 
593-600. 
Sperling, P., Ternes, P., Zank, T.K. and Heinz, E. The evolution of 
desaturases. Prostaglandins Leukot Essent Fatty Acids 68 (2003), pp. 
73-95. 
Sprecher, H. and Lee, C.J. The absence of an 8-desaturases in rat liver: a 
reevaluation of optional pathways for the metabolism of linoleic and 
linolenic acids. Biochim Biophys Acta 388 (1975), pp. 113-25. 
Stubhaug, I., Tocher, D.R., Bell, J.G., Dick, J.R. and Torstensen, B.E. Fatty 
acid metabolism in Atlantic salmon (Salmo salar L.) hepatocytes and 
influence of dietary vegetable oil. Biochim Biophys Acta 1734 (2005), 
pp. 277-88. 
Takagi, T. The Dehydrogenation of All-cis-5, 11, 14-Eicosatrienoic Acid to 
Arachidonic Acid. Bulletin of the Chemical Society of Japan 38 (1965), 
pp. 2055-2057. 
Thomas, E.A. and Yao, J.K. Clozapine specifically alters the arachidonic acid 
pathway in mice lacking apolipoprotein D. Schizophr Res 89 (2007), pp. 
147-53. 
Thomasson, H.J. Biological standardization of essential fatty acids; a new 
method. Int Z Vitaminforsch Beih 25 (1953), pp. 62-82. 
Tocher, D.R., Leaver, M.J. and Hodgson, P.A. Recent advances in the 
biochemistry and molecular biology of fatty acyl desaturases. Prog Lipid 
Res 37 (1998), pp. 73-117. 
Ullman, D. and Sprecher, H. An in vitro and in vivo study of the conversion of 
eicosa-11,14-dienoic acid to eicosa-5,11,14-trienoic acid and of the 
  54
conversion of eicosa-11-enoic acid to eicosa-5,11-dienoic acid in the 
rat. Biochim Biophys Acta 248 (1971), pp. 186-97. 
Van Pelt, C.K. and Brenna, J.T. Acetonitrile chemical ionization tandem mass 
spectrometry to locate double bonds in polyunsaturated fatty acid 
methyl esters. Anal Chem 71 (1999), pp. 1981-9. 
Voss, A., Reinhart, M., Sankarappa, S. and Sprecher, H. The metabolism of 
7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19-
docosahexaenoic acid in rat liver is independent of a 4-desaturase. J 
Biol Chem 266 (1991), pp. 19995-20000. 
Wallis, J.G. and Browse, J. The Delta8-desaturase of Euglena gracilis: an 
alternate pathway for synthesis of 20-carbon polyunsaturated fatty 
acids. Arch Biochem Biophys 365 (1999), pp. 307-16. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  55
CHAPTER 3 
 
NOVEL FATTY ACID DESATURASE 3 (FADS3) TRANSCRIPTS  
GENERATED BY ALTERNATIVE SPLICING2 
 
3.1. Introduction 
 
Long chain polyunsaturated fatty acids (LCPUFA), especially 
docosahexaenoic acid (DHA; 22:6n-3), eicosapentaenoic acid (EPA; 20:5n-3) 
and arachidonic acid (ARA; 20:4n-6) are ubiquitous in mammalian tissue and 
are indispensable for health, development and cognition (Carlson, 2001). They 
are essential constituents of phospholipid components of the biological 
membranes, are precursors for signaling eicosanoids and docosanoids that 
are major drug targets (e.g., COX-1, COX-2 inhibitors, leukotriene receptor 
antagonists), and are also known to regulate transcription of genes involved in 
lipid metabolism (Jump, 2002; Schmitz and Ecker, 2008). They can be 
obtained from the diet or are endogenously synthesized in the liver among 
many tissues, from dietary essential fatty acids (EFA) precursors, alpha-
linolenic acid (ALA; 18:3n-3) and linoleic acid (LA; 18:2n-6) by an alternating 
series of position-specific desaturation and carbon chain-elongation reactions.  
 
Fatty acid desaturases are enzymes that catalyze the introduction of cis 
double bonds at specific positions in a fatty acid chain.  FADS1, FADS2, and 
FADS3 are members of fatty acid desaturase gene family that arose 
evolutionarily from gene duplication.  They share high degree of sequence 
                                                 
2 Based on the reference of Gene, 2009 Oct 1;446(1):28-34. 
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homology, are clustered within the 100 kb region on the long arm of human 
chromosome 11q12-13.1, have the same exon/intron organization with 12 
exons and 11 introns, and are similarly organized on mouse chromosome 19 
(Nakamura and Nara, 2004).  The gene products of FADS1 and FADS2 have 
well defined functions as front end PUFA desaturases required for LCPUFA 
biosynthesis in mammals however no function has emerged for FADS3.  
 
Most known desaturase genes involved in PUFA biosynthesis contain the N-
terminal cytochrome b5 domain (HPGG) as electron donor and three histidine 
motifs “HXXXH, HXXHH and QXXHH”, conserved from human to microalgae 
(Sperling et al., 2003), however, there are exceptions (Sayanova et al., 2006). 
FADS1  codes for a 5-desaturase, and FADS2 codes for a 6-desaturase with 
many substrates, and has recently been shown to have 8-desaturase activity 
(Park et al., 2009).  Both genes are considered to yield a protein product(s) 
thought to operate on both n-3 and n-6 PUFA. The ∆6-desaturase (FADS2) 
operates on 18:3n-3 and 18:2n-6, resulting in the synthesis of 6,9,12,15-18:4 
and 6,9,12-18:3 (gamma-linolenic acid), respectively.  This step is rate-limiting, 
and is followed by elongation to 8,11,14,17-20:4 and 8,11,14-20:3 (dihomo-
gamma-linolenic acid).  A rapid ∆5-desaturation (FADS1) on these PUFA 
produces EPA and ARA.  EPA can be further elongated and desaturated to 
yield DHA, which is accepted as the mammalian pathway (Voss et al., 1991).  
These steps are certainly localized to the endoplasmic reticulum (ER), and a 
beta-oxidation step is localized to the peroxisomes, but have been suggested 
over the years to occur in mitochondria (Infante and Huszagh, 1998), or via a 
∆4-desaturase as demonstrated in Thraustochytrium (Qiu et al., 2001).  
Expression of FADS1 and FADS2 were detected in several human tissues 
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with greatest expression in liver for FADS1; FADS2 showed highest 
expression in the brain followed by liver, lung and heart.  Only a single 
transcript has been identified for both genes (Cho et al., 1999a; Cho et al., 
1999b).  
 
FADS3 was cloned by Marquardt et al (Marquardt et al., 2000). It spans 17.9 
kb of genomic DNA, shares a high degree of homology with FADS1 (52%) and 
with FADS2 (62%), and encodes a putative protein of 445 amino acids (aa) 
with a molecular mass of 51.1 kDa. FADS3 is among the six most highly 
expressed genes at the implantation site of fertilized mouse embryos in the 
interimplantation region (prior to implantation), suggesting a crucial role in the 
initiation of pregnancy (Ma et al., 2006).  However, the function of the FADS3 
gene product remains unknown. 
 
To date, there are no unambiguous reports of AT for any of the FADS genes.  
Two isoforms for FADS3 were detected with Northern blotting but an attempt 
to confirm them using RT-PCR was not successful (Marquardt et al., 2000).  In 
the course of investigation of the role of FADS3 in LCPUFA biosynthesis, we 
performed RT-PCR analysis using baboon neonate cDNA and detected 
multiple AT generated by alternative splicing events.  We report here 
characterization of FADS3 AT, their expression in twelve baboon neonate 
tissues and in human undifferentiated and differentiated neuroblastoma cells.  
 
 
 
 
  58
3.2. Materials and Methods 
 
Total RNA extraction and preparation of cDNA 
High quality neonate baboon tissues obtained at necropsy, treated with 
RNAlater, and maintained at -80°C, were used to isolate RNA. Total RNA from 
30 mg tissue homogenates was extracted using the RNeasy Mini kit (Qiagen, 
Valencia, CA). Total RNA yield was assessed by 260 nm UV absorption.  RNA 
quality was analyzed by 260/280 nm ratios of the samples and by agarose gel 
electrophoresis to verify RNA integrity. One microgram of DNase-treated total 
RNA was reverse-transcribed into first strand cDNA using the iScript cDNA 
synthesis kit (Bio-Rad, Hercules, CA). The resulting cDNA was used as 
template for PCR-reactions. 
 
RT(Reverse Transcription)-PCR and sequence analysis of FADS3 genes  
The protein coding region of baboon FADS3 and FADS3 AT were generated 
from primers synthesized using human FADS3 (NM_021727) and monkey 
FADS3 (XR_014740) mRNA sequences. Primer pairs are presented in 
Supplementary Table 2.1.  PCR primers were ordered from Integrated DNA 
Technologies (IDT, Coralville, IA) and were amplified by PCR with baboon 
liver, retina and spleen cDNA as templates and Ampli Taq Gold (Applied 
Biosystems, USA) in a 30 µl reaction volume containing 1µM of each primer, 
0.25 mM dNTPs, 10x PCR buffer, and 1.5 mM MgCl2 using Eppendorf gradient 
thermal cycler. Touch down PCR was performed for FADS3 amplification 
reactions, wherein annealing temperature was set between 72°C and 69°C for 
1 min for 40 cycles.  In addition to the band of expected size ~1.4 kb, some 
discrete bands were obtained in agarose gels.   The products were gel 
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purified, cloned in pGEM T-Easy vector (Promega, USA) and sequenced using 
T7 forward and SP6 reverse universal primers. DNA sequencing was 
performed at Cornell University Life Sciences Core Laboratories Center using 
the Applied Biosystems automated 3730 DNA analyzer.  
 
Mammalian cell culture and sample preparation 
SK-N-SH neuroblastoma cells (ATCC, USA) were grown at 37°C in a 
humidified environment with 5% CO2 using DMEM/F-12 with 10% FBS, 2mM 
L-alanyl-glutamine, and 15 mM HEPES for undifferentiated cells and routine 
passaging.   Cell differentiation was carried out in serum free  DMEM/F-12 
with 1X  N-2 supplement (Invitrogen, USA) containing 100 mg/L human 
transferrin, 5 mg/L recombinant full chain insulin, .0063 mg/L progesterone, 
16.1 mg/L putrescine, and .0052 mg/L sodium selenite (Bottenstein, 1992; 
Dong and Lim, 1996).  Cells were seeded in parallel and grown to 70% 
confluence in regular growth media with 10% FBS.  One flask of 
undifferentiated cells was then harvested for RNA extraction, while the 
remaining cells were switched to chemically defined N-2 supplemented media 
for an additional six days in order to halt growth and induce differentiation 
before harvesting.  RNA was isolated using the QIAshredder and RNeasy Mini 
kit (Qiagen, Valencia, CA). 
 
Expression of FADS3AT in baboon tissues and human cells 
To analyze the expression levels of each AT, primer pairs specific for each 
transcript bridging the deleted parts of the exons were designed 
(Supplementary Table 2.2). Tissue distribution of each transcript was 
measured using 12 normal tissues from a baboon neonate (12 weeks old) and 
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undifferentiated (embryonic stage) and differentiated SK-N-SH neuroblastoma 
cells by RT-PCR. For FADS3 AT PCR amplification reactions, annealing 
temperature was performed between 60-65°C for 30-40 cycles.  The PCR 
fragments generated from AT were cloned and sequenced. Amplicon size of 
each AT is presented in Supplementary Table 2.2. 
 
 
3.3. Results and Discussion 
 
Sequence analysis of baboon FADS3 
The sequencing of the expected ~1.4 kb PCR product (Baboon FADS3) 
revealed the presence of an open reading frame of 1,338 base pairs, encoding 
a putative protein of 445 aa and a stop codon. It shares a high degree of 
homology with other FADS genes (51% identity with baboon FADS1 
(EF531577) and 62% identity with baboon FADS2 (EU780003)). Like other 
front-end desaturases, baboon FADS3 protein also has “HPGG” (at aa 
positions 55-58) characteristic of Cytochrome b5 and three conserved histidine 
motifs “HXXXH, HXXHH and QXXHH”.  The human and baboon FADS3 
mRNA sequences align at a level of 97% identity along the entire coding 
region. Analysis and comparison of aa sequence of baboon FADS3 showed 
99% identity and 99% similarity with human FADS3 (NP_068373), and 54% 
identity and 70% similarity with bifunctional zebrafish desaturase (AAG25710).   
 
Sequence analysis of baboon FADS3AT 
When PCR products were separated on a 2% agarose gel, discrete bands of 
various sizes were detected in addition to the cDNA of the expected ~1.4 kb 
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size. All of the PCR products were gel purified, cloned and sequenced. Seven 
AT for baboon FADS3 were identified in addition to the classical transcript. 
The generated splice variants correspond to the absence of a portion of exon, 
complete absence of one or several exons, and retention of an intron. The 
FADS3 AT sequences are deposited at GenBank and were assigned the 
following GenBank Accession numbers EU780002, EU780004, FJ641198, 
FJ641199, FJ641200, FJ641201, FJ641202, and FJ641203. 
 
Using sequence analysis data with aid from ORF Finder, we identified the 
putative coding regions for eight AT for FADS3 with 1.34 kb (classical 
splicing), 1.14 (AT1), 0.77 (AT2), 1.25 (AT3), 0.51 (AT4), 0.74 (AT6), and 1.11 
(AT7). Figure 3.1 presents the structure of these AT.  In addition we identified 
an AT of 0.51 kb (AT5) length that has a termination codon within intron 8-9. 
Predicted protein sequences of the FADS3 AT indicate that three variants, 
AT1, AT3 and AT7, would produce shorter versions of the protein resulting 
from missing exon(s), whereas AT2, AT4, AT5 and AT6 would produce 
truncated proteins. AT1 lacks exon 3 due to an in-frame loss of 66 aa and AT3 
lacks a portion of exon 3 resulting from an in-frame loss of 28 aa.  Both AT1 
and AT3 retain all the conserved motifs characteristic of front end desaturases 
(“HPGG” Cytochrome b5 motif and three histidine repeats “HDLGH, HFQHH, 
QIEHH).  The absence of a portion of exon 8 together with exons 9-10 (AT7) 
results in an in-frame loss of 76 a.a and also results in the loss of the last 
histidine repeat “QIEHH”.  
 
In AT2, the skip of exon 6 causes a reading frameshift that results in the loss 
of the last histidine repeat “QIEHH”, and generates a truncated protein of 257  
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Figure 3.1. Baboon FADS3 and FADS3 AT. Missing spans within AT are 
shown. Numbers 1 to 12 are exons; CS, classical splicing; AT1-AT7 denote 
alternative transcripts. 
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aa.  AT4, AT5, and AT6 result from multiple exon deletions. AT4 lost HPGG 
and QIEHH, AT5 lost HPGG, HDLGH, and QIEHH, whereas, AT6 retains only 
HPGG while all the histidine repeats are lost from splicing events. Hastings et 
al. reported that substrate specificity can vary depending upon the differences 
in the sequence of a desaturase even though the catalytic activities are 
identical (Hastings et al., 2004). This raises the possibility that FADS3 AT 
might have different substrate specificities even though some of them share all 
the conserved catalytic domains.  
 
FADS3 conservation and putative subcellular localization of baboon 
FADS genes  
Figure 3.2 shows the alignment of FADS3 and its putative homologs from 
various species.  It can be seen that the “HPGG” characteristic of Cytochrome 
b5 and three conserved histidine motifs “HXXXH, HXXHH and QXXHH” are 
well conserved from human to microalgae. 
 
We used the Proteome analyst computational tool to query the subcellular 
localization of the FADS genes (Lu et al., 2004).  Amino acid sequence 
information is entered and the software provides an estimate of the probability 
that the protein is localized to a specific organelle. FADS1, FADS2, and 
FADS3 were all found to be localized to ER with a probability score of 1.000; 
FADS1 and FADS2 are known to code for ER proteins. Similarly an equivalent  
test for the mitochondria shows that FADS1 and FADS2 had probability scores 
of 0.529 and 0.562, respectively, whereas FADS3 was found to have a 
probability score of 0.999 for mitochondrial localization. This result suggests 
that FADS3 contains domains that are more commonly found in the  
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Figure 3.2. Alignment of amino acid sequences of FADS3.  Using 
MacVector software and ClustalW alignment, FADS3 aa sequences were 
aligned from various species. Well conserved motifs common for desaturases 
are depicted in boxes. The “HPGG” characteristic of a cytochrome b5 domain 
and three conserved histidine motifs “HXXXH, HXXHH and QXXHH” are 
shown in boxes. 
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mitochondria compared to FADS1 and FADS2, and may point to a 
mitochondrial role for one or more proteins for which the FADS3 codes. 
 
Expression of FADS3AT in baboon tissues and human cells  
Although FADS3 was cloned in 2000 (Marquardt et al., 2000), and was shown 
to be expressed in human heart, liver, lung, uterus and brain tissues, nothing 
is known about its function in LCPUFA biosynthesis.  We determined the 
tissue distribution and expression patterns of FADS3 AT in a baboon neonate 
and also determined the regulation patterns in human NB cells. To study the 
tissue distribution of FADS3 AT we performed semiquantitative RT-PCR using 
primer pairs bridging the deleted parts of the exons specific for each transcript, 
as shown in Supplementary Table 3.2. Figure 3.3 shows that all the variants 
are expressed in the 12 baboon neonate tissues studied. The AT2 variant was 
present in reproducibly smaller amounts in all 12 tissues. The primer pair 
designed to amplify AT3 also revealed the presence of a shorter amplicon 
(AT8?).  AT8 did not initially appear in our cloning screens, but is also 
expressed in all tissues. The sequencing of the shorter amplicon (~50 base 
pairs) showed deletion within exon 4.  Notably, the AT3 primer pair amplifies 
only AT8 in the occipital lobe region of the brain, whereas the remaining 11 
tissues express both AT3 and AT8 (Figure 3.3).  However, AT3 is highly 
expressed in the thymus, compared to other tissues. The highest levels of AT8 
were observed in occipital cortex lobe, pancreas, skeletal muscle and heart,  
 
with much lower levels in thymus. Our RT-PCR analysis using primers 
specifically designed to amplify AT5 also confirms that intron 8-9 remains in 
the transcript, and it is strongly expressed in immune tissues (thymus and  
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Figure 3.3. FADS3 AT expression in 12 Baboon Neonate Tissues.  RT-
PCR analysis of FADS3 AT shows expression in 12 baboon neonate tissues. 
The amplified products were resolved on a 2% agarose gel, visualized with 
ethidium bromide and a negative image is shown.   Legend:  bp, base pair. 
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spleen) and the heart. These data support the hypothesis that FADS3 AT 
encode functionally important proteins.  
 
Expression of FADS3 AT in response to cell differentiation was also 
investigated using human SK-N-SH neuroblastoma (NB) cells.  Figure 4 
shows that all the variants are found to be expressed in these cells. However, 
they showed reciprocal increases and decreases in expression pattern in 
response to cell differentiation (Figure 3.4). One of the most striking 
observations is the significant down-regulation of AT5 expression in 
differentiated and significant up-regulation in undifferentiated NB cells. 
Different patterns of expression of AT show that these transcripts are under 
specific control during the NB cell differentiation.  Our data demonstrate that 
the FADS3 AS events widely detected in baboon tissues are also conserved in 
human cells. A recent estimate shows splicing level differences of 6-8% 
between orthologous human and primate (chimpanzee) transcripts and 4% in 
genes having one or more cassette alternative exons, compared to 80% 
differences between human and mouse genes (Calarco et al., 2007). 
 
 
FADS-coded PUFA desaturases and putative isoforms 
AS, first proposed by Gilbert (Gilbert, 1978), is rapidly gaining importance as 
an essential molecular mechanism whereby a single gene transcript can give 
rise to a number of spliced mRNAs to generate remarkable protein diversity. 
 
 
Blencowe  suggested that AS may be the most extensively used 
posttranscriptional modification of genes (Blencowe, 2006). Modrek et al.  
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Figure 3.4. FADS3 AT expression in human SK-N-SH Neuroblastoma 
(NB) Cells.  RT-PCR analysis of FADS3 AT shows expression in human SK-
N-SH neuroblastoma (NB) cells.  M represents a 100 base pair molecular size 
marker; AT1-AT7 represent alternatively spliced variants; C-Beta-actin 
Control; Diff, differentiated cells, Undiff, undifferentiated cells. 
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performed genome-wide analysis to test AS events using a human EST 
database analysis and found that the majority of splicing events (74%) occur in 
coding regions, followed by 5’-UTR (22%) and 3’-UTR (4%) (Modrek et al., 
2001).  
 
Modrek et al. (Modrek et al., 2001) assessed the systemic functions affected 
by AS events in human genes and found that many were specific to immune 
and nervous systems. LCPUFA are highly concentrated in membranes of the 
nervous system and serve as substrates for signaling molecules. Diets rich in 
n-6 PUFA induce various physiological and metabolic changes leading 
towards proinflammatory status with production of series 2 prostaglandins and 
series 4 leukotrienes, whereas n-3 PUFA have opposite effects (Benatti et al., 
2004). The well known, pioneering 1963 work of Mohrhauser and Holman 
showed that rat liver PUFA composition is related to the ratio of 18:3n-3 and 
18:2n-6 in the diet (Mohrhauer and Holman, 1963a; Mohrhauer and Holman, 
1963b). Vertebrate desaturase and elongation enzymes operate on both the 
n-3 and n-6 PUFA families. However, alternative hypotheses involving n-3 or 
n-6 specific desaturases have been proposed from time to time which suggest 
that the competition may, at least in part, be “apparent”. A compelling example 
is the reciprocal changes in concentration of 22:6n-3 and 22:5n-6 that are 
found associated with specific metabolic conditions, for instance in tissues of 
Zellweger’s syndrome (Martinez, 1992) or adrenoleukodystrophy (ALD) 
patients(Martinez, 1990), acyl CoA knockout (Acox ko) mice (Infante et al., 
2002), and in vitamin A deficient mice (Zhou et al., 2004). In Zellweger’s, ALD, 
and Acox ko, 22:6n-3 drops while 22:5n-6 rises; however, in vitamin A 
deficient mice, the opposite is found: 22:6n-3 rises and 22:5n-6 drops. The 
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latter paper (Zhou et al., 2004) specifically suggests, as we have (Infante et 
al., 2002), that common enzyme pathways for 22:6n-3 and 22:5n-6 cannot 
explain these results. Plausible hypotheses are that isoforms based on FADS 
AT exist that operate with high selectivity on specific PUFA and are differently 
regulated, and/or that the unknown function(s) of FADS3 are PUFA-specific. A 
vertebrate 5-desaturase with all the characteristics of microsomal desaturases, 
including 63% identity with the human 5-desaturase (FADS1), and with 
significant activity only towards n-3 PUFA (20:4n-3) has been reported in 
Atlantic salmon (Hastings et al., 2004).  An early study of PUFA synthesis in 
mammalian cells concluded that separate enzymes may exist for the n-3 and 
n-6 PUFA (Maeda et al., 1978).  A mitochondrial pathway involving separate 
PUFA desaturases for n-6 and n-3 fatty acids was postulated to explain 
observed features of LCPUFA biosynthesis (Infante and Huszagh, 1998).  
 
Many isoforms of stearoyl CoA desaturase (SCD) are known in many species, 
expressed in a tissue specific manner (Dridi et al., 2007), but thusfar no AT of 
any of the PUFA-specific desaturases are known, other than the ones that we 
present in this study.  The data of figures 3 and 4 show that AT of PUFA-
specific desaturases exist in primates, and support the hypothesis that AT 
have different roles because of their differential expression. Molecular 
regulation of PUFA desaturases produced by classical splicing of FADS1 and 
FADS2, respectively, are well studied, but nothing is known about FADS3 
regulation. Both FADS1 and FADS2 are regulated by macro and 
micronutrients, hormones and multiple transcription factors (Brenner, 1981; 
Zolfaghari and Ross, 2003; Nakamura and Nara, 2004). Identifying the 
substrate specificities of these novel FADS3 transcripts and functions 
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associated with them will help in better understanding the cellular processes 
mediated by PUFA and their metabolites.  
 
 
3.4. Conclusion 
 
This is the first finding of AT of FADS genes. We present in vivo and in vitro 
evidence that at least 9 novel FADS3 AT, including AT8, are generated by 
splicing events.  The FADS3 AT are expressed in many tissues and showed 
changes in abundance in response to human neuronal cell differentiation. 
FADS3 AT function is as yet unknown but their structure, and high sequence 
homology to functional FADS1 and FADS2, strongly implies that they are 
involved in LCPUFA biosynthesis.  LCPUFA are ubiquitous components of 
cells and tissues that can be, but are not always, obtained in the diet.  Intense 
interest in LCPUFA metabolism is related to the wide range of human intakes 
compared to requirements for optimal health.  The most recent frontiers 
include diseases of aging (e.g., Alzheimer’s disease) and psychiatric/affective 
disorders. Determining the function of FADS3 AT, conserved among species, 
provides a putative mechanism for understanding of LCPUFA biosynthetic 
regulation, and how it differs among individuals. 
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APPENDIX 
 
Supplementary Table 3.1.  
Primer pairs used to generate protein coding regions of Baboon FADS3 and FADS3 alternative transcripts 
 
FADS3  Primers Forward Primer Reverse Primer Amplify Transcripts 
Primer Pair1 ATGGGCGGCGTCGGGGAGCCCGGT TGGTTGCTGGTGCCCTGAG
CS, AT1, AT2, 
AT3, AT6 and 
AT7 
Primer Pair2 TGCTCGGACCTCGGCCACCGCCT TGGTTGCTGGTGCCCTGAG AT4 
Primer Pair3 TCTTGCTCGGACCTCGGCCACCGCCT TGGTTGCTGGTGCCCTGAG AT5 
 
Primer pair 1: Forward primer was designed using monkey GenBank Accession (XR_014740) and reverse primer 
was derived from Human FADS3 published by Marquardt et al. 2000 (Genomics 66, 175-83). 
Primer pair 2: Forward primer was designed using human FADS3 GenBank Accession (NM_021727) targetting 5' 
UTR region and reverse primer was derived from Human FADS3 published by Marquardt et al. 2000 (Genomics 
66, 175-83). 
Primer pair 3: Forward primer was designed using human FADS3 GenBank Accession (NM_021727) targetting 5' 
UTR region and reverse primer was derived from Human FADS3 published by Marquardt et al. 2000 (Genomics 
66, 175-83). 
CS-Classical transcript 
AT1-AT7-Alternative transcripts 
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Supplementary Table 3.2. 
Primer pair’s specific for each alternative transcript (bridging the deleted parts of the exons) of FADS3 
 
FADS3 
AT 
Primers 
Forward Primer Reverse Primer 
Amplicon 
Size (Base 
Pairs) 
AT1 TGAATGCTCAGTCCTGGTGTCTGCA ACATGGTTCCACCGGGACTTCTTGA 76 
AT2 ACCACGCCAAGCCCAACATCTT AGCAGCGGCGGGCCGACTCGA 99 
AT3 ATCCTGGCCATGGAGGCTCAGTCCTG AACTTCTGGGCCACATGGTTCCACC 98 
AT4 TGCAGTGGGCGGGTCCTGGAGAGCCA TCATGGCCGATCTCCTTGGGGATGT 80 
AT5 TCTTTGTTGCTGTCAGGTATGGCAGG TCACATGATTCCGCCAGCAAGCCA 152 
AT6 CTTCATCCTGGGCCAGCTCTCAGCT AAGAGGTGGTGCTCGATCTGGAAGT 109 
AT7 TTCTTATCCTACCTCTTCCCCAGGAT TTCACTTCGTAGCTGAGGCCGTGCTT 104 
Beta-
Actin ATTGCCGACAGGATGCAGAA AAGCATTTGCGGTGGACGAT 200 
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CHAPTER 4 
 
ALTERNATIVE SPLICING GENERATES A NOVEL FADS2 ALTERNATIVE 
TRANSCRIPT IN BABOONS3 
 
 
4.1. Introduction 
 
Fatty acid desaturases are enzymes that catalyze the introduction of cis 
double bonds at specific positions in a fatty acid chain. FADS1 and FADS2 are 
genes coding key desaturase enzymes for the biosynthesis of long chain 
polyunsaturated fatty acids (LCPUFA), and are referred as ‘front end’ 
desaturases (Marquardt et al., 2000; Nakamura and Nara, 2004). Fatty acid 
desaturase 2 (FADS2) codes for a protein that catalyzes the first and rate 
limiting step in the biosynthesis of LCPUFA from 18 carbon PUFA.  In 
mammals, the FADS2 gene product catalyzes 6-desaturation in at least five 
substrates, 18:2n-6, 18:3n-3, 24:5n-3, 24:4n-6, and 16:0 (D'Andrea et al., 
2002; Guillou et al., 2004). Recently, we demonstrated that the primate 
FADS2 gene product also catalyzes 8-desaturation, using substrates 20:2n-6 
and 20:3n-3, which were previously thought to be dead end products (Park et 
al., 2009a).   
 
We recently reported the first finding of alternate transcripts (AT) of the FADS2 
and FADS1 paralog FADS3 elsewhere (Park et al., 2009b).  In this study, we 
                                                 
3 Based on the reference of Mol Biol Rep.  DOI: 10.1007/s11033-009-9750-9 
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report a transcript variant of FADS2 in fetal baboon brain generated by 
alternative splicing, as well as evidence that it is widely expressed in baboon 
neonate tissues and in human SK-N-SH neuroblastoma (NB) cells.   
 
4.2. Materials and methods 
 
Fetal baboon brain tissue was obtained from banked tissue at the Southwest 
Foundation for Biomedical Research (San Antonio, Tx).  Neonate baboon 
tissues originated from a 12 week old baboon fed an infant formula with no 
LCPUFA from a previous study (Hsieh et al., 2007).  All tissues were 
maintained at -80°C since necropsy until RNA isolation. 
 
RNA isolation and cDNA synthesis:  
Total RNA was extracted from baboon tissue homogenates and SK-N-SH 
neuroblastoma (NB) cells using the RNeasy Mini kit (Qiagen, Valencia, CA). 
The yield of total RNA was assessed by 260 nm UV absorption. The quality of 
RNA was analyzed by 260/280 nm ratios of the samples and by agarose gel 
electrophoresis to verify RNA integrity. One microgram total RNA was reverse 
transcribed into first-strand cDNA using the iScript cDNA synthesis kit (Bio-
Rad, Hercules, CA). The resulting cDNA was stored at -20°C until use.  
 
PCR conditions and identification of alternative transcript:  
We have earlier (Park et al., 2009a)  reported the protein coding region of 
baboon FADS2 (GenBank accession number EU780003) using primers 
FADS2 forward: ATGGGGAAGGGAGGGAACCAGGGCGA and FADS2 
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reverse: TCATTTGTGAAGGTAGGCGTCCAGCCA. The above primers were 
used to perform polymerase chain reaction (30 µl) with baboon fetal brain 
tissue cDNA as template, 1 µM of each primer, 0.25 mM each of dNTPs, 1.5 
mM MgCl2, 5X PCR buffer, and high-fidelity Taq polymerase (Roche 
Diagnostics Ltd) in an Eppendorf gradient thermal cycler.  Cycling conditions 
were: initial denaturation at 95°C for 5 min followed by 40 cycles of 
denaturation at 95°C for 30 s, annealing at 72°C for 45 s and extension at 
72°C for 1 min, with a final extension at 72°C for 5 min.  Two prominent bands 
were obtained when separated by electrophoresis on a 2% agarose gel. The 
two bands were gel purified,  cloned into pGEM T-Easy vector (Promega, 
USA) and sequenced using T7 forward and SP6 reverse universal primers at 
the Cornell University Life Sciences Core Laboratories. 
 
Mammalian cell culture and sample preparation:  
SK-N-SH neuroblastoma (NB) cells (ATCC, USA) were grown in a humidified 
environment at 37°C with 5% CO2 using DMEM/F-12 with 10% FBS, 2mM L-
alanyl-glutamine, and 15 mM HEPES for undifferentiated cells and routine 
passaging.   NB cell differentiation was carried out in serum free  DMEM/F-12 
with 1X  N-2 supplement (Invitrogen, USA) containing 100 mg/L human 
transferrin, 5 mg/L recombinant full chain insulin, 0.0063 mg/L progesterone, 
16.1 mg/L putrescine, and .0052 mg/L sodium selenite  (Bottenstein, 1992; 
Dong and Lim, 1996).  Cells were seeded in parallel and grown to 70% 
confluence in regular growth media with 10% FBS.  One flask of 
undifferentiated cells was then harvested for RNA extraction, while the 
remaining cells were switched to the chemically defined N-2 supplemented 
media for an additional six days in order to halt growth and induce 
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differentiation before harvesting.  RNA was extracted using the QIAshredder 
and RNeasy Mini kit (Qiagen, Valencia, CA). 
 
 
Expression of FADS2 and AT1 in baboon tissues and human cells:  
To analyze the expression of FADS2 CS, a forward primer was designed 
within the exonic region that is deleted in the alternative transcript. To amplify 
FADS2 AT1, the forward primer bridged the deleted parts of exons. 
 
FADS2 CS Primer sequences: 
Forward: AGGCCCAAGCTGGATGGCTGCAA 
Reverse: AGTTGGCAGAGGCACCCTTTAAG 
 
FADS2 AT1 Primer sequences: 
Forward: AGAAGCATAACCTGTCTGTCTACA  
Reverse:  ATGATTCCACCAGTTGGCAGAG  
 
The tissue distribution of each transcript was measured by RT-PCR using 
cDNA from 12 normal tissues from a baboon neonate (12 weeks old), and in 
undifferentiated (embryonic stage) and differentiated SK-N-SH neuroblastoma 
cells. PCR amplification reactions were performed using 1 µM of each primer, 
0.25 mM each of dNTPs, 1.5 mM MgCl2 and AmpliTaq Gold (ABI, Foster City, 
CA) in a final volume of 30 µl. Cycling conditions were: initial denaturation at 
95°C for 5 min followed by 35 cycles of denaturation at 95°C for 30 s, 
annealing at 67°C for 45 s and extension at 72°C for 1 min, with a final 
extension at 72°C for 5 min.  PCR products were separated on 2% agarose 
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gels, and the PureLink™ Gel Extraction Kit (Invitrogen) was used to isolate the 
PCR bands. The amplicons were sequenced to confirm identity.  
 
 
4.3. Results and Discussion 
 
Previously, we cloned and sequenced the entire protein coding region of 
baboon FADS2, GenBank accession number EU780003, using baboon 
neonate liver cDNA.  However, in addition to the expected size PCR band we 
noticed another prominent amplified product using baboon fetal brain cDNA 
(Figure 4.1). Product sequencing resulted in the identification of an 873 bp 
FADS2 alternative transcript (AT1) with a C/T substitution at nucleotide 
position 327 (GenBank Accession# FJ901343). The splice variant has 
truncated exons 1 and 4 and skipped exons 2 and 3 (Figure 4.2). The putative 
coding region 0.9 kb for AT1 resulting from an in-frame loss of 154 aa was 
identified using ORF finder <http://www.ncbi.nlm.nih.gov/projects/gorf/>. Two 
of the conserved motifs characteristic of front end desaturases (“HPGG” 
Cytochrome b5 motif and the first histidine repeat “HDYGH”) are lost during 
the splicing event.  
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Figure 4.1. FADS2 CS- Classical splicing, FADS2 AT1 is alternative 
splicing. The products were separated on 2% agarose gel, visualized with 
ethidium bromide and a negative image of photograph is shown. Lane 1: 100 
base pair molecular weight marker and Lane 2: PCR products amplified by 
RT-PCR  
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Figure 4.2.   FADS2 CS- Classical splicing, FADS2 AT1 is the novel 
alternative transcript. Missing spans within AT1 are shown. Numbers 1 to 12 
are exons, CS- Classical Splicing, AT1- alternative transcript 
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Expression profiling:   
To investigate if AT1 expression is limited to the fetus, we studied the 
expression of FADS2 classically spliced (FADS2 CS) and AT1 in 12 neonate 
baboon tissues and in human SK-N-SH neuroblastoma (NB) cells (figure 4.3 
and figure 4.4).  FADS2 CS expression was greater than AT1 in all tissues 
examined, and displayed relatively little variability, with noticeably lower 
expression only in kidney.  AT1 expression was highly variable, showing 
greater expression in liver, retina, occipital lobe, hippocampus, spleen, and 
ovary, than in other tissues.  FADS2 CS and AT1 were also expressed in 
undifferentiated and differentiated NB cells with no obvious difference in 
expression levels.  
 
Putative subcellular localization:   
FADS2 CS and FADS2 AT1 putative subcellular localization prediction was 
achieved using the web-based tool, Proteome Analyst Specialized Subcellular 
Localization Server (PA-SUB) (Lu et al., 2004). The software takes amino acid 
sequence information in FASTA format and provides an estimate of the 
probability that the protein location within a cell. Both FADS2 CS and FADS2 
AT1 were found to be localized to endoplasmic reticulum (ER) with a 
probability score of 1.000 and to be localized to mitochondria with probability 
scores of 0.562 and 0.999, respectively. FADS2 CS is known to code for ER 
proteins. However, the above results suggest a mitochondrial role, as well as 
an ER role, for FADS2 AT1. 
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Figure 4.3.  FADS2 and AT1 expression in 12 neonate baboon tissues 
(lane 1: liver, lane 2: kidney, lane 3: retina, lane 4: occipital lobe, lane 5: 
hippocampus, lane 6: heart, lane 7: skeletal muscle, lane 8: lung, lane 9: 
spleen, lane 10: thymus, lane 11: pancreas, lane 12: ovary)   
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Figure 4.4. FADS2 and AT1 expression in human SK-N-SH 
neuroblastoma (NB) cells (lane 1: undifferentiated NB cells, lane 2: 
differentiated NB cells) 
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Functional characterization studies remain to be implemented to understand 
the physiological significance of the co-expression of AT1 along with FADS2.  
Although FADS2 AT1 is missing apparently conserved domains, in the 
flowering plant Anemone leveillei, a desaturase has been described without 
the cytochrome b5 domain catalyzed synthesis of non-methylene-interrupted 
(non-conjugated) PUFA.  This observation shows that the four common 
domains are not required for production of functional protein (Sayanova et al., 
2007).  Qualitatively, expression levels appear to follow the tissue 
concentrations of 22 carbon LCPUFA.  Confirmation of this observation would 
suggest a role in the regulation or biosynthesis of LCPUFA from precursors. 
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CHAPTER 5 
 
ALTERNATIVE TRANSCRIPTS OF  
FATTY ACID DESATURASE (FADS) GENES 
 
 
5.1. Introduction 
 
The interconversion of polyunsaturated fatty acids (PUFA) in mammals has 
long been known to be mediated by desaturation, elongation, and β-oxidation 
activities.  Biosynthesis of long chain PUFA (LCPUFA) from the eighteen 
carbon precursors linoleic acid (LA, 18:2n-6) and linolenic acid (ALA, 18:3n-3) 
is especially important because of the prevalence of 18:2n-6 and 18:3n-3 in 
the human food supply.   
 
Figure 5.1 is an outline of the currently accepted pathways for LCPUFA 
biosynthesis starting from 18:2n-6 and 18:3n-3, with genes and associated 
activities shown.  In vertebrates, desaturation and elongation takes place in 
the endoplasmic reticulum (ER), apart from a report of 5-desaturase activity in 
the nuclei (Ves-Losada and Brenner, 1995).  β-oxidation activity is found in the 
peroxisomes and mitochondria, including a critical step leading directly to 
22:6n-3 biosynthesis from 24:6n-3 (Sprecher et al., 1995).  β-oxidation 
catalyzes chain shortening interconversion, while the fatty acid chain 
elongation system operating on PUFA via three genes (ELOVL2, 4, and 5) 
(Jakobsson et al., 2006) chain lengthens.   
 
  94
PUFA desaturation activity is mediated by the Fatty Acid Desaturases (FADS) 
gene cluster located within a 100 kb region of the long arm of human 
chromosome 11q12-13.1, with the homologous genes located on mouse 
chromosome 19 (Nakamura and Nara, 2004).  FADS1, 2, and 3 are consist of 
12 exons and 11 introns, and include 3 conserved his box motifs and a 
cytochrome b5 motif.  FADS1 (Cho et al., 1999a) gene products were first 
established as having ∆5-desaturase activity catalyzing 20:3n-6 Æ 20:4n-6 
(arachidonic acid, ARA) and 20:4n-3 Æ 20:5n-3 (eicosapentaenoic acid, EPA).  
FADS2 (Cho et al., 1999b) gene products have ∆6-desaturase activity 
catalyzing 18:2n-6 Æ 18:3n-6 and 18:3n-3 Æ 18:4n-3; based on in vitro 
assays (Su and Brenna, 1998),  ∆6-desaturation is generally considered the 
rate limiting step for LCPUFA biosynthesis.  FADS3 (Marquardt et al., 2000) 
shares similar sequence homology to FADS1 and FADS2 as the latter two 
genes are to one another.  Despite the congruence of sequence similarity, no 
function has emerged for FADS3. 
 
Recent studies have detected associations between specific single nucleotide 
polymorphisms (SNP) in FADS genes and blood fatty acid levels in normal 
adults (Schaeffer et al., 2006; Gieger et al., 2008; Rzehak et al., 2008), adults 
with cardiovascular disease (Malerba et al., 2008), pregnant and lactating 
women (Xie and Innis, 2008), and in attention-deficit/hyperactivity disorder 
(ADHD) (Brookes et al., 2006).  More than 90% of SNPs that are associated 
with fatty acid concentrations are located in the untranslated regions, in 
introns, and in the intergene regions in CpG islands. Mechanisms that may be 
influenced by these non-coding regions are differential promoter binding and 
changes in methylation patterns that alter transcription.  
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Figure 5.1.  Biosynthesis of LCPUFA with emphasis on the role of FADS 
genes, as generally accepted.  β-oxidation may chain shorten any LCPUFA.  
Not shown are 16:2n-6 and 16:3n-3 which can be elongated to 18:2n-6, and 
18:3n-3, respectively. 
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Another possibility is genome-wide alternative splicing (AS) events that yield 
alternative transcripts (AT) (Gilbert, 1978).  The majority of AT result from full 
or partial exon deletion or intron retention.  AT may code for modified proteins 
with different specificities than the protein coded by the transcript resulting 
from classical splicing (CS), or serve some regulatory role.  AT serve to 
expand the range of products for which a genome can code.  It has been 
estimated that 90% of multi-exon genes have alternative transcripts.  In a 
remarkable example of AS, the Drosophila gene Down syndrome cell 
adhesion molecule (Dscam) potentially generates over 38,000 transmembrane 
proteins of the immunoglobulin superfamily (Hattori et al., 2007) that function 
in the development of neural circuitry, and specifically in dendritic self-
avoidance (Matthews et al., 2007).  Metabolic regulation of AT expression has 
also been reported.  For instance, ABCA1, a gene required for lipid transport 
across the plasma membrane has at least three AT that are regulated in a 
tissue and diet specific manner (Singaraja et al., 2005).   
 
Recently, we have re-examined various aspects of the pathways of LCPUFA 
biosynthesis, showing, for instance, that the FADS2 gene product catalyzes 
the ∆8-desaturation of 20:2n-6 Æ 20:3n-6 and 20:3n-3 Æ 20:4n-3 (Park et al., 
2009a).  In the course of these molecular studies we discovered AT 
associated with FADS3 (Park et al., 2009b) and, most recently, FADS2 (Park 
et al., 2009c).  We discuss here salient aspects of these first reports of FADS 
AT and their possible implications for LCPUFA biosynthesis. 
 
Table 5.1 outlines the number of transcripts, proteins, and activities reported 
for the mammalian FADS genes.  FADS1 function is limited to ∆5-desaturation  
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Table 5.1. Current knowledge of primate PUFA desaturases. 
 
 
 
Gene FADS1 FADS2 FADS3 
Transcript(s) 1 2 8 (9?) 
Protein Not characterized 
Activities 
∆5-desaturation 
 
20:3n-6Æ20:4n-6 
20:4n-3Æ20:5n-3 
∆6-desaturation  
18:2n-6Æ18:3n-6 
18:3n-3Æ18:3n-3 
24:5n-3Æ24:6n-3 
24:4n-6Æ24:5n-6 
16:0Æ16:1n-10 
 
∆8-desaturation  
20:2n-6Æ20:3n-6 
20:3n-3Æ20:4n-3 
Not identified 
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of the 20 carbon precursors of ARA and EPA.  FADS2 has a much wider 
substrate spectrum.  Its microsomal activity is about one quarter that of 
∆5-desaturation (Su and Brenna, 1998), and it prefers n-3 to n-6 PUFA.  It also 
shows small ∆8-desaturation activity toward 20 carbon PUFA in the presence 
of 18 carbon substrates (Park et al., 2009a).  Finally, FADS2 apparently 
mediates the biosynthesis of sapienic acid (16:1n-10), the most abundant 
unsaturated fatty acid on human skin, though the activity on 16:0 as a 
substrate is low (Ge et al., 2003).  FADS3 has no known substrates.  
Analogous PUFA desaturase genes reported in other species, including fish 
(Hastings et al., 2004), C. elegans (Spychalla et al., 1997), and many plant 
species (e.g. (Sayanova et al., 2007)) have a much wider range of substrates 
and specificities than those of mammals. 
 
 
4.2. FADS3 AT 
 
We recently described the detection of 7 AT of FADS3 in 12 tissues of three 
month old baboons (Park et al., 2009b).  AT are numbered sequentially 
according to the order in which they were discovered.  Figure 5.2 is an 
alignment of predicted amino acid sequences for the FADS3 CS and AT.  AT1 
and AT2 are missing exons 3 or 6, respectively.  FADS3 AT3 has a truncated 
version of exon three; AT4 has a truncated exon 1, truncated exon 3, and is 
missing exons 2 and 8; AT5 has a truncated exons 1 and 4 and is missing 
exons 2 and 3, as well as retaining intron 8-9; AT6 skips the span from part of 
exon 4 through part of exon 9; AT7 skips part of  exon 8 and all of exons 9 and 
10.  Predicted protein sequences indicate that AT1, AT3, and AT7 would code  
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Figure 5.2.  Alignment of Baboon FADS3 alternative transcripts using 
MacVector software and ClustalW alignment. Well conserved motifs 
common for desaturases are depicted in boxes. The “HPGG” characteristic of 
Cytochrome b5 is boxed in red, whereas three conserved histidine motifs 
“HDLGH, HFQHH and QIEHH” are shown in blue boxes. 
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for shorter proteins; AT1 and AT3 retain all conserved motifs characteristic of 
PUFA desaturases (HPGG cytochrome b5 and three histidine repeats 
“HDLGH, HFQHH, QIEHH”).  The deletion of part of exon 8 and all of exons 9-
10 result in the loss of the last histidine repeat QIEHH in AT7.  AT2, AT4, AT5, 
and AT6 would produce truncated proteins missing one or more motifs.  
 
The FADS3 AT were cloned into yeast (Saccharomyces cerevisiae) and 
mammalian cells, but showed no activity toward a variety of PUFA substrates 
(our unpublished data, 2009).  Further studies were carried out to detect 
FADS3 AT expression in baboon tissue and cultured human neuroblastoma 
cells using AT-specific PCR primers bridging deleted parts of exons.  
Remarkably, all seven AT, were detected in all baboon tissues and in human 
cells (Park et al., 2009b).  Figure 5.3 shows expression relative to β-actin for 
12 tissues.  Summed expression of all AT was highest in hippocampus and 
more than double that in pancreas; summed expression in all tissues was 
highest for AT6, and more than triple that of AT2.  Correlation analysis of 
these data were performed using JMP 7.0 (SAS Institute, Cary, NC, USA) for 
the 21 possible pairs of 7 different AT.  Results are shown in Table 5.2 for the 
significant correlations (p<0.05).  Six of the seven correlations are among 
FADS3 AT4, 5, 6, and 7.  These results imply coordinated expression of these  
 
AT in tissues, and also imply that expression of the other AT are independent.  
FADS3 AT4,5,6,and 7 putatively code for truncated proteins that, individually, 
are all missing one or two of the four conserved motifs, and all are missing the 
QIEHH at the 3’ end.  It is tempting to speculate that simultaneous translation 
of all these ATs would code for proteins that could bind to form one or more  
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Figure 5.3. Expression of the seven FADS3 AT in 12 tissues of a 12 week 
old baboon.  Data are arranged left to right in order of total expression 
relative to β-actin.  Gels were scanned and quantified manually using ImageJ 
<http://rsbweb.nih.gov/ij/>. 
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Table 5.2. Significant correlations between AT in various tissues4. 
 
 
 
 
 
 
 
 
 
                                                 
4 Calculated with JMP 7.0 <http://www.jmp.com/>, “Multivariate Methods >Multivariate” menu and 
activation of “pairwise correlations" to obtain p values 
 r2 P 
AT7 – AT4 0.79 0.0001 
AT5 – AT4 0.77 0.0002 
AT7 – AT6 0.74 0.0003 
AT4 – AT6 0.68 0.0010 
AT5 – AT7 0.55 0.0055 
AT5 – AT6 0.46 0.0150 
AT3 – AT1 0.37 0.0352 
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functional desaturases, possibly to enable activity toward multiple substrates 
or for purposes of regulation. 
 
 
5.3. FADS2  AT 
 
Figure 5.4 presents quantitative data on the expression of FADS2 CS and AT1 
in the same twelve organs of baboon neonate as in Figure 5.3. Liver 
expression of FADS2 CS is 4-fold that of the average expression of the other 
organs.  The range of expression in the other organs is 2-fold, from the highest 
in retina to the lowest in skeletal muscle.  In contrast, the range for FADS2 
AT1 in these same tissues varies over a factor of 20, from highest again in 
occipital lobe to the lowest in thymus.  The dramatic difference in expression 
suggests a difference in function and independent regulation.   
 
Preliminary observations on species conservation of FADS AT.    The 
conservation of alternatively spliced transcript variants of FADS AT was 
examined in several animal species, as shown in Figure 5.5. Using 
the baboon-specific primers (Park et al., 2009c) for each of the FADS AT, we 
performed RT-PCR analysis using liver cDNA from mice, pig (porcine), dog, 
fox, chicken and horse. At least five of the seven FADS3 AT and FADS2 
AT1 are reproducible in many species. These PCR products have not yet 
been confirmed by sequencing, but are consistent with the hypothesis that 
FADS AT perform some functionally important role, encoding proteins or 
performing a regulatory role. 
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Figure 5.4. Expression of the FADS2 classically spliced (CS) transcript 
and AT1 in various tissues of a 12 week old baboon.  The y-axis is plotted 
with liver FADS2 CS off-scale because it is four-fold the average of the others.  
The range of expression for FADS2 AT1 is much greater among the 11 tissues 
(other than liver) than for the CS. 
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Figure 5.5.  Expression of FADS3 AT and FADS2 AT1 in five mammalian 
species and in the chick, analyzed using baboon-specific primers.  All but 
FADS3 AT2 and FADS3 AT5 are expressed in most of the species.  FADS3 
AT5 is detected in horse.  
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More than one investigator of desaturase function has suggested that the 
existence of at least two different 6-desaturases as a possible explanation of 
functional studies (Bourre and Piciotti, 1992; Marzo et al., 1996).  To our 
knowledge, isozymes of a ∆6-desaturase have been described only in the 
arachidonic acid producing fungus Mortierella sp. and not for other organisms 
(Sakuradani and Shimizu, 2003; Nakamura and Nara, 2004).  In previous 
work, we and others have also suggested that specific LCPUFA synthases 
would explain results of ours and others that are not easily accounted for by 
the accepted LCPUFA synthesis pathways (Infante and Huszagh, 1998; 
Infante et al., 2002).  Although a function has yet to emerge for FADS3 and for 
the various AT that we have described, they represent a putative molecular 
basis on which alternative regulation and LCPUFA biosynthetic pathways 
could be based.   
 
Hypothetically, FADS AT as mediators of LCPUFA biosynthesis or regulation 
could have implications for establishing variability in individual and population 
LCPUFA dietary requirements.  Among the few studies that have reported on 
stable isotope tracers in humans, at least one in preterm infants showed wide 
variability to form 22:6n-3 and 20:4n-6 (Uauy et al., 2000). Differential 
expression of AT among individuals in response to diets could imply 
differential LCPUFA requirements.  For instance, some populations subsisting 
on diets that provide only 18:2n-6 and 18:3n-3 as PUFA may require 
supplementary LCPUFA because of low expression of putative AT-related 
LCPUFA synthetic proteins, while others might synthesize sufficient LCPUFA 
from precursors.  Group differences of this type have been suggested (Gibson 
and Sinclair, 1981) but no compelling data has been presented.  The novel 
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findings of FADS AT suggest that investigations to elucidate molecular 
mechanisms and nutritional factors regulating their expression are required to 
elucidate factors mediating human PUFA desaturation. 
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CHAPTER 6 
 
CONCLUSION AND FURTHER STUDIES 
 
6.1. Conclusion 
 
Scientific and public interest in the relationship between dietary fatty acids, 
especially long chain polyunsaturated fatty acids (LCPUFA), and human 
health has been high for decades because of their nutritional importance 
throughout the development and aging. LCPUFA, namely DHA, EPA, and 
ARA are ubiquitous in the mammalian tissue, achieving highest concentrations 
in the membranes of neural and other excitable tissue, and contribute 
significantly to human and animal health, development, and cognition 
(Carlson, 2001; Brenna and Diau, 2007). The composition of these fatty acids 
affects the biological membrane integrity and fluidity, eicosanoid synthesis, 
critical molecules in eicosanoid signaling for physiological homeostasis, 
protein-lipid interactions, membrane bound receptor function and regulation of 
gene expression (Nakamura and Nara, 2004; Kothapalli et al., 2007). 
Especially, DHA and ARA are major LCPUFA of vertebrate central nervous 
system (CNS) and are known to be important in infant brain development and 
in maintenance of adult brains. Deficiency of omega-3 fatty acids results in 
decrease of DHA in the brain and retina, which in turn may lead to memory 
loss, learning disabilities, and impaired visual activity (Benatti et al., 2004; 
Hsieh and Brenna, 2009).  
 
The parent PUFA 18:2n-6 and 18:3n-3 are components of all human diets, 
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and the LCPUFA can be biosynthesized from them, though the adequacy of 
biosynthesis is in question. Vertebrates are unable to biosynthesize LCPUFA 
de novo as they lack ∆12 and ∆15 desaturase enzymes responsible for 
converting 18:1n-9 (oleic acid) into 18:2n-6 and then into 18:3n-3 (Pereira et 
al., 2003). The essentiality of 18:2n-6 and 18:3n-3 in vertebrates has been 
known for decades. The main sources of 18:2 are sunflower oil, safflower oil, 
soybean, corn, and cottonseed, and 18:3 is derived from green leafy 
vegetables, canola, flaxseed, soybean, and walnuts (Simopoulos, 1999). 
LCPUFA are not readily available in many western diets and their endogenous 
synthesis from dietary precursors, 18:2n-6 and 18:3n-3 requires an alternating 
series of position-specific desaturation and carbon chain-elongation reactions. 
The focus of my research dissertation is desaturation steps.  
 
FADS1 and FADS2 genes which encode for ∆5 and ∆6 desaturation, 
respectively, are considered to yield protein product(s) thought to operate on 
both n-3 and n-6 PUFA. FADS2 catalyzes the rate limiting step acting on 
parent PUFA 18:2n-6 and 18:3n-3 in the biosynthetic pathway for LCPUFA 
biosynthesis. In addition to 18:2 and 18:3, FADS2 uses at least three more 
substrates, 24:6n-3, 24:5n-3 and 16:0. However, there are no previous reports 
of FADS2 gene product activity toward 20 carbon PUFA. The existence of an 
alternative pathway for the biosynthesis of 20:4n-6 and 20:5n-3 was first 
observed in a protozoan (Euglena gracilis). In this microorganism 18:2n-6 and 
18:3n-3 are first elongated to 20:2n-6 and 20:3n-3, followed by delta 8 
desaturation and delta 5 desaturation, respectively to yield 20:4n-6 and 20:5n-
3. The existence of delta 8 desaturation activity has been reported in rodent 
and human testes and the most recent study shows stable isotope labeling 
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best explained by direct conversion of 11,14-20:2 to 20:4n-6 via ∆8-
desaturation, albeit as a minor pathway, but there are no existing molecular 
data to implicate a specific gene responsible for coding for vertebrate ∆8-
desaturase activity. In mammals, 20:2n-6 and 20:3n-3 are widely considered 
dead-end products, in part because their conversion to LCPUFA has not been 
unequivocally established. We hypothesized that the primate FADS2 gene 
product would have ∆8-desaturase activity and cloned baboon FADS2 into 
Saccharomyces cerevisiae, an organism with no native PUFA biosynthetic 
capability, to test for gain of ∆8-desaturation activity. By using gas 
chromatography-covalent adduct chemical ionization tandem mass 
spectrometry (GC-CACI-MS/MS) and quantitatively analyzed by GC-flame 
ionization detection (GC-FID) we identified new product peaks in FADS2 
transformed yeast cells incubated with 20:2n-6 and 20:3n-3 substrates. After 
establishing the ∆8-desaturase activity towards 20 carbon PUFA, we studied 
the relative activity in competition experiments. The ∆8-desaturase activity 
toward n-3 and n-6 fatty acids was investigated by supplementing media with a 
1:1 mixture of 20:2n-6 and 20:3n-3 as substrates and we found a relative 
conversion efficiency of ~3.1-fold, favoring the n-3 PUFA. Similarly, 1:1 
mixtures of 18:2n-6+20:2n-6 or 18:3n-3+20:3n-3 were added to media to test 
the relative ∆6-desaturase and ∆8-desaturase activities. We found that, ∆6-
desaturation activity was preferred to ∆8-desaturation activity by 7-fold for n-6 
(18:2n-6 over 20:2n-6) and by 23-fold for n-3 (18:3n-3 over 20:3n-3), 
respectively. Our results suggest that the conventional pathway would be 
strongly favored when both substrates are available and also establishes the 
affinity of the biosynthetic apparatus favoring n-3 PUFA. Our data established 
the unambiguous molecular evidence of the existence of ∆8-desaturation in 
  117
primates, suggesting alternative pathway for LCPUFA biosynthesis (Park et 
al., 2009a). From our results, we consider ∆8-desaturation to be a minor 
pathway; however, in individuals homozygous for the minor alleles for several 
SNPs in FADS gene cluster, especially FADS2 (Schaeffer et al., 2006) ∆8-
desaturation may well be the only or major pathway. In these individuals 
18:2n-6 desaturation product 18:3n-6 is decreased, whereas the elongation 
product 20:2n-6 is increased.  
 
Alternative splicing (AS), first proposed by Gilbert (Gilbert, 1978), is now 
becoming well recognized as an important molecular mechanism for 
expanding protein diversity in higher eukaryotes. AS, initially thought to affect 
very small number of genes, but recent evidence shows at least 95% of 
multiexon genes have alternative transcripts (Calarco et al., 2009). FADS 
(FADS1, FADS2 and FADS3) gene cluster is localized within a 100 kb region 
on the long arm of human chromosome 11q12-13.1, similar organization is 
reported on mice chromosome 19 (Nakamura and Nara, 2004). There are 
previous reports suggesting the existence of alternative transcripts (AT) for 
FADS genes, but none have been reported in the literature so far.  In the 
course of investigation the role of FADS genes in LCPUFA biosynthesis, we 
performed RT-PCR analysis using baboon fetal and neonate cDNA and 
detected an AT for FADS2 and multiple AT for FADS3 generated by 
alternative splicing events (Park et al., 2009b; Park et al., 2009c). Using ORF 
finder, we also determined the putative coding regions of FADSAT.  
 
At least 8 AT were identified for FADS3 with 1.34 kb (classical splicing), 1.14 
(AT1), 0.77 (AT2), 1.25 (AT3), 0.51 (AT4), 0.74 (AT6), and 1.11 (AT7). In 
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addition, we identified an AT of 0.51 kb (AT5) length that has a termination 
codon within intron 8–9. AT1 and AT2 lost exons 3 or 6, respectively.  AT3 has 
a portion of exon three missing; AT4 has missing parts of exon 1 and exon 3 
and complete loss of exons 2 and 8; AT5 has a truncated exons 1 and 4 and 
is missing exons 2 and 3, as well as retaining intron 8-9; AT6 skips the span 
from part of exon 4 through part of exon 9; AT7 skips part of exon 8 and all of 
exons 9 and 10.  Predicted protein sequences indicate that AT1, AT3, and 
AT7 would code for shorter proteins; AT1 and AT3 retain all conserved motifs 
characteristic of PUFA desaturases (HPGG cytochrome b5 and three histidine 
repeats “HDLGH, HFQHH, QIEHH”).  The deletion of part of exon 8 and all of 
exons 9-10 result in the loss of the last histidine repeat QIEHH in AT7.  AT2, 
AT4, AT5, and AT6 would produce truncated proteins missing one or more 
motifs. FADS2AT1 resulted from the partial or complete loss of first four exons 
causes in-frame loss of 154 aa and generates a coding region of 0.9 kb.  
 
The FADS2 AT and FADS3 AT are expressed in twelve neonate baboon 
tissues and human neuronal cells. FADS3 AT also showed changes in 
abundance in response to human neuronal cell differentiation. The correlation 
analysis of 7 FADS3 AT showed that most significant correlations are among 
FADS3 AT3 4, 5, 6, and 7, having implication that expression of those AT may 
be coordinated, however, other AT probably are independently expressed in 
tissues. Though the function of FASD3 is unknown, in vivo and in vitro FADS3 
AT gene expression, as well as structural and high sequence proximity to 
FADS1 and FADS2, suggest that FADS3 AT may relate to LCPUFA synthesis 
and/or regulation and have physiologically important roles.  
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The gene expression of FADS2 classical transcript is higher than FADS2AT1 
in all baboon tissues and showed very little variability. However, in the same 
tissues AT1 expression varies over a factor of 20, from highest in occipital lobe 
to the lowest in thymus. Qualitatively, expression levels appear to follow the 
tissue concentrations of 22 carbon LCPUFA. The dramatic difference in 
expression suggests a difference in function and independent regulation.   
 
We also found that these AT are well conserved across several mammalian 
and avian species. Determining the function of these AT, conserved among 
species, provides a putative mechanism for understanding of LCPUFA 
biosynthetic regulation, and how it differs among individuals. 
 
 
6.2. Further studies 
 
The ∆8 desaturation alternative pathway to the eicosanoid precursors may 
explain data suggesting that 20:2n-6 levels are related to human health. All 
available evidence indicates that ∆8-desaturation is a minor pathway, but 
further study may show that it becomes important when there is high demand 
for eicosanoid synthesis, such as in inflammation or vasodilation, particularly in 
situations in which specialized tissues require 20:3n-6 as a precursor to 
prostaglandins E1 and F1α, hydroxyeicosatrienoic acids, or thromboxane B1.  
 
The novel findings of FADS AT suggest that investigations to elucidate 
molecular mechanisms and nutritional factors regulating their expression are 
required to elucidate factors mediating human PUFA desaturation. Identifying 
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the functions for FADSAT is a uniquely important key to vertebrate physiology, 
and specifically the nervous system, which cannot function without 
polyunsaturated fatty acids.  
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